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 Abstract 
The development of new and improved biomaterials is essential for tissue engineering and 
regenerative medicine applications. Amino acid-based polyphosphazenes are being explored 
as scaffold materials for tissue engineering applications due to their non-toxic degradation 
products and tunable material properties. This work focuses on the synthesis of non-
functional and novel functional poly[(amino acid ester)phosphazene]s using a facile method 
of thermal ring opening polymerization followed by one-pot room temperature substitution.  
The family of polyphosphazenes developed in this work is based on L-alanine (PP-A’s), L-
phenylalanine (PP-F’s), and L-methionine (PP-M’s) with L-glutamic acid imparting the 
functionality.  Characterization of these materials demonstrated that the one-pot substitution 
was successful in developing mono- and co-substituted poly[(amino acid 
ester)phosphazene]s. Cytotoxicity studies on two-dimensional films showed these materials 
to be compatible with  NIH-3T3 fibroblasts over the five-day study.  The PP-F’s also showed 
significantly enhanced cell viability over tissue culture polystyrene at day 1 (p<0.001) and 
day 3 (p<0.01). As a proof of concept, electrospinning of PP-A100 blended with 
poly(caprolactone) (PCL) (50% PP-A100/50% PCL) was conducted to fabricate three-
dimensional scaffolds. Overall, this study has shown that poly[(amino acid 
ester)phosphazene]s can be synthesized with good yields and better reaction conditions, 
leading to materials with promising cytocompatibility for use in biomedical applications. 
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Chapter 1  
1 Scope and Thesis Outline 
1.1 Scope 
As the fields of tissue engineering and regenerative medicine continue to emerge as 
promising alternatives to current treatment options for failed or otherwise diseased 
tissues, so too has the development of suitable biomaterials.1 Materials-mediated tissue 
engineering is the most frequently employed strategy, where a porous scaffold, which is 
ideally degradable, acts as a support for the developing tissue either in vitro or in vivo. 
The scaffolds themselves must possess specific material and biological characteristics, 
such as desirable mechanical properties, degradation rates that parallel tissue formation, 
and biocompatibility, to ensure their success in tissue engineering applications.1 As such, 
numerous natural and synthetic materials have been investigated for their use in 
biomedical applications.2-4  Natural materials, like cellulose, chitosan, and collagen, have 
been extensively studied due to their inherent biocompatibility and favourable cell-
material interactions; however, they fall short as ideal materials due to their uncontrolled 
degradation rates, poor mechanical properties, and batch-to-batch variability.4 Synthetic 
polymers, on the other hand, have shown to be an improvement over natural materials 
with their tunable and well-controlled mechanical properties and degradation rates, ease 
of processing, and availability.5, 6 That being said, degradable synthetic polymers, like 
poly(acids), have their own drawbacks such as the formation of acidic degradation 
products.7-9 Another limitation of synthetic materials is their inability to instruct cells 
since they do not contain the biochemical cues that are present on the native extracellular 
matrix, which direct proper tissue formation.10, 11 Therefore, degradable biomaterials that 
can be tailored with respect to mechanical and degradation properties to suit their 
intended applications and that degrade into non-toxic products are being actively 
pursued.1, 5  
Polyphosphazenes, especially poly[(amino acid ester)phosphazene]s, have been shown to 
have tunable material properties and degrade into non-toxic degradation products that are 
easily dealt with by the body, making them great candidates for use as scaffold 
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biomaterials.12, 13 Since these materials are based on amino acids, it is also possible to 
incorporate functionality into the polymers, which would allow for subsequent 
attachment of biomolecules shown to improve cell-material properties, potentially 
overcoming the main inadequacy of current synthetic materials. Current synthetic 
methods for the fabrication of poly[(amino acid ester)phosphazene]s are cumbersome14 
and development of a facile synthesis technique would make studying these materials 
more accessible. With increased accessibility of poly[(amino acid ester)phosphazene]s, 
these materials could be studied for their utility in a wider range of applications not just 
orthopaedics, which has been the main application to date.15 Also, the facile synthesis 
would allow for the development of novel co-substituted poly[(amino acid 
ester)phosphazene]s with functional handles for biomolecule conjugation. In this work, a 
facile synthesis of poly[(amino acid ester)phosphazene]s was developed and the resulting 
materials were characterized extensively, investigated for cytotoxicity, and explored for 
their potential in fabricating three-dimensional constructs. 
1.2 Thesis Outline 
This thesis contains five chapters. Chapter 2 provides an in-depth literature review of 
tissue engineering, requirements of scaffold biomaterials, current natural and synthetic 
materials and their limitations, the synthesis of polyphosphazenes, and the suitability of 
polyphosphazenes as biomaterials in terms of biocompatibility, degradability, and 
mechanical properties. The rationale and objectives for this work are also included at the 
end of Chapter 2.  Chapter 3 describes the materials and methods for the synthesis of the 
poly[(amino acid ester)phosphazene]s materials, as well as the setup parameters and 
experimental conditions for characterization, cell studies, and electrospinning 
experiments. Chapter 4 presents and discusses all research findings of this work. Lastly, 
Chapter 5 provides a general conclusion of the major findings in this study and future 
directives for this project. 
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Chapter 2  
2 Literature Review, Objectives, and Rationale* 
2.1 Tissue Engineering Methodology  
There are four main strategies of tissue engineering that could be explored for tissue 
repair and remodeling, cell transplantation, scaffold transplantation, and two forms of 
cell-seeded scaffold transplantation.  The cell transplantation strategy involves simply 
injecting cells, whether they are stem cells or primary cells, to the damaged area and 
allowing the cells to interact with the natural extracellular matrix (ECM) and mature into 
working tissue in vivo.  In this case, the host body serves as the “bioreactor” that 
produces the necessary mechanical stimulation and other signals to guide the maturation 
and remodeling process. A limitation of this technique is that despite injection of the cells 
to the damaged tissue, functional tissue generation is not guaranteed.16  The rejection of 
the cells by the host’s immune system can also be problematic as cell sources are 
typically from donors or sources other than the patients themselves.17, 18  The new cells 
are also required to secrete their own ECM support system to fully integrate with the 
existing tissue and if the necessary cues are not received by the cells this may not occur.19   
The second strategy of tissue engineering tackles the development of new tissues from a 
scaffold-based approach. In this approach, an unseeded scaffold, which can be based on 
natural4, 5, 10 or synthetic material1, 5, is implanted directly into the patient and relies on 
the already present neighboring cells to migrate and infiltrate the scaffold.  The types of 
scaffolds used in this technique can range from natural polymers to synthetic materials, 
both of which maybe either stable or degradable. If cell migration cues on the scaffold are 
missing or the cells do not interact favourably with the material, infiltration may be poor, 
leading to a tissue with limited functionality and poor success rates.20   
                                                 
* Parts of this chapter have been published: Baillargeon, Amanda L; Mequanint, Kibret, Biodegradable 
Polyphosphazene Biomaterials for Tissue Engineering and Delivery of Therapeutics.  Biomed. Res. Int. vol. 
2014, Article ID 761373, 16 pages, 2014. doi:10.1155/2014/761373 
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The last two paradigms of tissue engineering both rely on the use of an external cell 
source and scaffold to create the new tissue.  The first type, cell-seeded scaffold 
implantation, involves transplanting the scaffold into the patient following seeding the 
cells onto the scaffold and allowing them to begin to adhere.  In this method, the new 
tissue relies on the patient’s body to act as the “bioreactor” for in vivo tissue maturation 
and remodeling, while the cell-seeded scaffold receives signals from the surrounding 
tissues and experiences mechanical forces and other stimuli to properly guide the tissue 
maturation process.  In the second type, in vitro tissue engineering (Figure 2.1), the cell-
seeded scaffold is allowed to mature in an artificial bioreactor in vitro prior to 
implantation in the patient.  In the bioreactor, the scaffold and cells are subjected to 
appropriate forces, such as pulsatile flow and shear forces simulating those experienced 
in native vessels for the development of tissue-engineered blood vessels, in order to 
improve the maturation process to form completely functional tissues prior to 
implantation.16 These stimuli, along with other factors including chemical signals, have 
been shown to affect the development of functionally viable tissues, especially the 
phenotype of vascular smooth muscle cells in vascular tissue engineering, and therefore 
are important in generating useful tissue-engineered graft materials.21  These two 
methods often include the incorporation of biomolecules alongside the cells and scaffold 
that can improve cell-material interactions and enhance signaling for proper development 
of a functional tissue.  These biomolecules are typically growth factors and other small 
protein molecules that can direct the proliferation, migration, and adhesion of cells onto 
the scaffold material.22  The scaffolds themselves serve as a temporary template for the 
cells to proliferate on until they are capable of secreting their own natural ECM as 
support, and therefore must have the appropriate cell-material interactions and material 
properties.  If biostable materials are selected, it is important to consider not only the 
mechanical properties of the scaffold material, but also the characteristics of the scaffold 
and newly secreted ECM together, making sure that these match the material properties 
of the native tissue.  If a degradable material is chosen, it is ideal for the degradation rate 
of the material to be comparable to the rate of secretion of the ECM by the cells.  Overall, 
ideal materials for all forms of scaffold-guided tissue engineering are yet to be realized 
and are still under investigation, which is the basis for this research. 
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Figure 2.1: A diagrammatic representation of the in vitro tissue engineering process; 
where a cell-seeded scaffold is matured in vitro in a bioreactor prior to implantation 
into the patient. 
2.2 Requirements of Tissue Engineering Scaffolds 
In order for a scaffold to be successful in tissue engineering applications it should mimic 
the natural ECM of the tissue that is being repaired, regenerated, or replaced in both 
material and biological properties.23, 24  By mirroring the ECM, the likelihood of 
developing functional tissues is improved by encouraging proper cell proliferation, 
migration, adhesion, and tissue assembly.  The scaffolds themselves can be based on 
either natural polymers, such as collagen, elastin, chitosan, and hyaluronic acid, or 
synthetic polymers designed to mimic natural materials.4, 5, 10  Another key factor to 
consider is the wide range of ECM morphology and structural arrangement across tissue 
types, which is important for directing proper cell growth, and should therefore be closely 
emulated in the natural and synthetic scaffolds using appropriate fabrication methods.25 
The biological and material properties of scaffolds, described in detail below, are one of 
the remaining critical issues in tissue engineering and serve as a guideline for the 
development of new scaffold biomaterials.1 
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The material properties that are important to consider are mechanical properties, porosity, 
processability, degradability, surface chemistry, and sterilizability.  In terms of 
mechanical properties, the materials must be physically strong in order to withstand 
normal forces experienced within the specific type of tissue being engineered.26 For 
example, in blood vessels the tissues experience shear forces and pulsatile blood flow, so 
the materials should have adequate tensile strength and elastic modulus to endure these 
forces.27  The natural ECM is highly porous allowing for substantial cell infiltration and 
the development of complex tissues, likewise, the scaffold materials should be porous 
and give cells the necessary space to penetrate, explore, and adhere throughout the 3-D 
scaffold.28-30  Along with high porosity, there should also be a high surface area-to-
volume ratio and appropriate pore diameters to accommodate the type of cells seeded into 
the structure. This ensures that the cells are not only capable of infiltrating through the 
pores, but also have sufficient surface area on which they can adhere. It is also important 
that the pores of the scaffold are uniformly distributed across the 3-D construct and that 
the pores are interconnected, allowing the cells to explore freely throughout the entire 
matrix without encountering blockages. By selecting an appropriate fabrication 
technique, such as freeze drying, solvent casting/particulate leaching, or electrospinning, 
the desired characteristics of the scaffold can be achieved, such as a specific average pore 
size and structural arrangement,.29-32 In solvent casting/particulate leaching methods, for 
example, the pore size of the resulting scaffold can be well controlled by selecting a 
porogen of appropriate diameter and selectively dissolving these out of the scaffold once 
the polymer matrix is fully set.33, 34  Some limiting factors to consider when selecting a 
fabrication method is the processability of the material, including properties such a 
melting temperature (Tm), glass transition temperature (Tg), decomposition temperature 
(Td), and solubility in appropriate solvents.  For instance, solvent casting/particulate 
leaching cannot be employed if there are no two solvents available that selectively 
dissolve only the polymer in one and only the porogen in the other.33  The degradability 
of scaffolds was described above in scaffold-based tissue engineering (Section 2.1), 
although if degradable materials are to be used, it should be noted that their degradation 
rate should coordinate well with the secretion rate of the new ECM by the cells.  This will 
ensure adequate mechanical strength of the scaffold and that there is sufficient support 
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material for the proliferating cells.32, 35  Cells not only migrate along the scaffold surface, 
but they also form focal adhesions and interact with the material itself.  In order to 
improve cell-material interactions and encourage the proliferation and adhesion of the 
cells throughout the scaffold, it is important to include surface chemistry that is 
favourable for cells on the materials.30, 36  In synthetic polymers this can be realized by 
incorporating functional handles on the material surface that allow for the attachment of 
biomolecules known to enhance cell-material interactions and cell proliferation.  Lastly, 
as these materials will eventually be implanted in patients, they must be sterilizable to 
minimize the chance of bacterial and other small organismal infections in the patient 
from the tissue-engineered constructs.   
The biological requirements of scaffolds have been touched upon in the material 
properties discussion, although the key traits they must possess include biocompatibility 
and promotion of cell proliferation and adhesion. Considering the fact that these materials 
will undoubtedly be used in vivo, they must not elicit immune response in the patients 
that would be harmful to their well-being, including any degradation products in the case 
of degradable materials. As such, materials are studied extensively in vitro and in vivo 
prior to clinical trials, exploring cytoxicity, cell morphology, and inflammatory response, 
to name a few.37 The tissue-engineered product, including the scaffold, must also interact 
favourably and incorporate well with the existing tissues. 
In conclusion, it is necessary to consider both the material and biological properties of 
both natural polymers and synthetic materials used for scaffold fabrication, like those 
described in the proceeding sections, to ensure they are well-suited for their intended 
tissue engineering application.   
2.2.1 Natural Polymers 
Natural materials for scaffolds are often based on ECM components such as collagen3, 29, 
38, 39, fibrinogen40-42, hyaluronic acid43-45 and glycosaminoglycans (GAGs)46, 47 since these 
materials have the bioactivity and compatibility required of a scaffold biomaterial. Other 
natural materials such as chitosan, gelatin, and cellulose4, 48 are also known to be highly 
biocompatible and therefore have been extensively studied for tissue engineering and 
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other biomedical applications. The main advantage of natural materials is that they 
intrinsically contain biological cues and signal molecules required for proper cell 
adhesion and migration, which are lacking with unmodified synthetic materials, thus 
limiting suitable cell-material interactions.  Recently, Chen et al.25 developed knit silk-
collagen scaffolds for tendon tissue engineering applications, that when seeded with 
human embryonic stem cell-derived mesenchymal stem cells caused overexpression of 
scleraxis; a tendon differentiation marker protein by the cells ideal for tendon 
regeneration. Also, He et al. 49 fabricated aligned electrospun scaffolds of cellulose 
nanocrystal reinforced nanocomposites for tissue engineering applications. The scaffolds 
showed improved tensile and elastic properties and displayed non-toxic behavior in 
toxicity assays with primary human dental follicle cells. The main drawbacks of natural 
materials are their inadequate mechanical strength, uncontrolled degradation rates, poorly 
defined structure, batch-to-batch variability, and limitations with purification and 
sterilization processes leading to immunorejection.1, 4 These limitations have directed 
researchers to investigate synthetic polymers as an alternative to natural materials.    
2.2.2 Biodegradable Synthetic Polymers 
Biodegradability is a desirable feature of a biomaterial used in tissue engineering since 
the goal for it is to act as a temporary scaffold, holding the growing tissue in place until 
the natural ECM has developed sufficiently. Beyond that point, the scaffold should break 
down into non-toxic degradation products capable of being disposed of by the body, 
leaving only the newly formed tissue.  Synthetic polymers have the advantages of being 
relatively inexpensive and readily available over natural materials.  They also have 
tunable material properties that can be matched to the intended application, whereas 
natural polymers have set material properties that limit their use in a range of 
applications. There are a wide variety of synthetic biodegradable polymers that have 
been, and continue to be, explored, including polyesters, polyanhydrides, polyacetals, and 
poly (α-amino acids).50-55 Recently, Kim et al.56 fabricated a poly(ethylene glycol) 
dimethacrylate and gelatin methacrylate-based hydrogel scaffold with controlled stiffness 
and degradation properties for use in vascular tissue engineering.  The scaffold was 
shown to improve human umbilical vein endothelial cell attachment with elongated 
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morphology showing progress towards improved in vivo endothelialization of tissue-
engineered small diameter vascular grafts, which has previously been a limitation in that 
field.  Amino acid-based synthetic polymers have been of great interest for biomedical 
applications due to the fact that part of their degradation products are naturally occurring 
amino acids, which are handled well by the body.  Poly(ester amide)s53, 55 are one branch 
of these polymers and have been shown not only to be biocompatible with various cell 
types, but are also capable of being formed into 3-D constructs via various scaffold 
fabrication techniques. Despite their improvement over natural polymers with regards to 
degradation and mechanical properties, synthetic polymers have their own limitations.  
Control of mechanical and degradation properties of synthetic polymers are limited when 
the synthesis of materials is based on a single monomer, such as the case with polyesters. 
Another common problem with synthetic polymers, such as poly(lactic acid) (PLA), is 
the formation of acidic products during the degradation process which leads to 
diminished mechanical strength of the material and compromised cell function in the 
acidic environment.7-9 Unfunctionalized synthetic materials have a tendency to interact 
poorly with cells due to the lack of biological signaling molecules present on the material 
surface, unlike the native ECM which is rich in biomolecules for proper cell-material 
interactions.  The quest for biomaterials with tunable degradation rates and mechanical 
properties, but that also maintain cell function and lack the formation of toxic degradation 
products is an active area of research.6, 57  
2.2.3 Biomimetic Materials 
In order to improve the efficiency of interactions between synthetic polymers and cells, 
the materials are often modified, either chemically or physically, prior to seeding cells 
into the scaffold materials. Typical biological cues present on the natural ECM include 
hormones, growth factors, and other small protein molecules, which direct cell adhesion, 
proliferation, and migration. These molecules can be incorporated into synthetic materials 
via bulk or surface modifications, although bulk modifications can significantly alter the 
material properties of polymers.11  Surface alterations, on the other hand, only slightly 
change the material properties of the polymers, thus maintaining the mechanical strength 
of the scaffolds after modification.  Physical attachment of biomolecules is usually 
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achieved via adsorption, which relies on non-covalent bonding (hydrophobic interactions, 
hydrogen bonding, etc.). The main disadvantage of this method is that the biochemical 
signals can leach away from the scaffold when exposed to culture media, potentially 
resulting in a diminished effect of the biomolecule on cell-material interactions.  When 
chemical modification is used instead, the molecules are retained at the scaffold surface 
by covalent linkages, which are not disrupted when the scaffold is submerged in culture 
media, leading to prolonged biomolecule-mediated cell-material interactions.11 Chemical 
linking of the bioactive compound to the material is limited by the availability of 
functional groups on the surface of the materials which can be reacted with available 
reactive sites on the biomolecule.  This can be overcome by developing biomaterials that 
contain reactive groups as functional handles for biomolecule conjugation, like the 
carboxylic acid group of glutamic acid that has been explored in this work. 
2.2.4 Scaffold Fabrication 
In order for a biomaterial to be useful in tissue engineering applications, it must be 
processable into a 3-D construct since natural tissues are inherently three-dimensional.  
Traditional fabrication methods that have been studied extensively include freeze-drying, 
fiber bonding, and solvent casting/particulate leaching.33, 51, 58  More recently, researchers 
have been exploring electrospinning as a scaffold fabrication method due to its versatility 
in forming fibers with diameters from the micron range down to the nanometer range.59, 60 
The non-woven fibrous mats can also be collected and formed into specific construct 
shapes, such as tubular for application in vascular tissue engineering, based on the type of 
collector used and other spinning modifications.11, 60  The electrospinning process 
involves the application of theories of electrostatic repulsion and surface tension, 
resulting in the formation of a very small jet of polymer solution, which is then collected 
as fibers on a collector.  The general setup for electrospinning includes a high voltage DC 
power supply, a syringe pump and syringe containing the polymer solution, and a 
grounded collector upon which the fibers are deposited.  A solution containing the 
desired concentration of polymer in a suitable solvent is prepared and loaded into a 
syringe secured on the syringe pump.  A needle on the end of the syringe is attached to 
the high voltage source and a ground is attached to the collector, which can be stationary 
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or rotating.  The syringe pump begins to push the polymer solution into the needle tip 
where the voltage induces a charge on the solution.  Within the needle tip there is a fine 
balance between the surface tension forces keeping the solution together and the 
electrostatic repulsive forces driving the solution to spread.  When the electrostatic forces 
exceed the surface tension, a polymer jet escapes the needle and begins to travel towards 
the grounded collector.60, 61 During flight, the polymer jet experiences whipping 
instability, which increases travel time and path length to the collector.  This increase in 
travel time allows sufficient time for the majority of the solvent to evaporate, leaving 
only the polymer behind as fibers on the collector and decreasing fiber diameter.30, 62, 63  
By optimizing the solution and processing variables (e.g. solvent, concentration, voltage, 
distance to the collector, flow rate, needle diameter, etc.), fibers with well-defined 
diameters and morphology are achievable, which in turn affects the construct’s 
mechanical properties.63-65  Overall, electrospinning is an ideal process for developing   
3-D scaffolds for tissue engineering applications due to its relatively inexpensive setup 
and adaptability for numerous applications.    
2.3 Synthesis of Polyphosphazenes 
Sustained research towards new biomaterials for tissue engineering and regenerative 
medicine applications has led to the utilization of polyphosphazenes as a class of novel 
materials.  Polyphosphazenes are comprised of an inorganic backbone of repeating 
phosphorus and nitrogen atoms with alternating single and double bonds (Figure 2.2, 
Structure 1c). Extending from each of the phosphorus atoms are two organic side chains, 
which can range from alkoxy and aryloxy substituents to amino acids, giving a large 
variety of potential polymers. Changing the organic side groups and their ratios, if 
multiple different side groups are attached to the same polymer backbone, allows 
substantial tunability of the physical, mechanical, and degradation properties of the 
material. Therefore, altering the organic substituents can be quite useful in tailoring the 
mechanical properties and degradation rates of the biomaterial to suit the desired tissue 
engineering application, such as bone tissue or blood vessels, which require drastically 
different properties.  
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Figure 2.2: Structures of various polyphosphazenes including steroidal substituents 
(2), carbohydrates (3), amino acid esters (4), and side chain bound amino acid esters 
(5), to name a few. 
The synthesis of polyphosphazenes, as shown in Scheme 2.1, are typically synthesized 
via a two-step reaction, beginning with the thermal ring opening polymerization of 
hexachlorocyclotriphosphazene (1a), the cyclic trimer, to the linear 
poly[(dichloro)phosphazene] (1b) precursor. Next, the organic side chains are attached to 
the polymer backbone through a nucleophilic macromolecular substitution of the organic 
substituents for the phosphorus-bound chlorine atoms.66-68 The following two sections 
will succinctly describe the individual steps of poly(organophosphazene) synthesis, 
showing the different chemical routes previously reported and the vast range of materials 
that can be generated. 
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2.3.1 Polymerization to Poly[(dichloro)phosphazene] 
2.3.1.1 Thermal Ring Opening Polymerization – Bulk Phase 
Although the thermal ring polymerization of the trimer (1a) to linear 
poly[(dichloro)phosphazene] was attempted in the late 1800s by H. N. Stokes69, a useful 
material that was soluble and capable of being functionalized was not realized until the 
1960s.  The initial thermal ring opening polymerization performed by Stokes led to a 
product that was insoluble, due to crosslinking, and that was readily susceptible to 
hydrolysis when exposed to moisture. In 1965, Allcock and Kugel70 were able to 
synthesize linear poly[(dichloro)phosphazene] through a well-controlled thermal ring 
opening polymerization from the cyclic trimer hexachlorocyclotriphosphazene according 
to Scheme 2.1. The product obtained was soluble, allowing it to be modified further by 
macromolecular substitution of the reactive P-Cl bonds with organic and organometallic 
nucleophiles. The thermal ring opening polymerization technique developed by Allcock 
et al. is the most commonly used route to prepare the linear poly[(dichloro)phosphazene] 
precursor.15, 67 A typical process involves reacting hexachlorocyclotriphosphazene trimer, 
which was purified via sublimation techniques prior to reaction, at 250°C over 5 days in 
an evacuated polymerization tube with continuous rocking of the reaction vessel. At this 
point, soluble poly[(dichloro)phosphazene] has been formed and can be purified and 
functionalized via the macromolecular substitution reaction (Scheme 2.1, 1a  1b).67 
The yields obtained for these reactions reached a maximum of 75%. 
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Scheme 2.1: Scheme showing the synthesis and functionalization of 
poly[(dichloro)phosphazene] (1b) in the overall synthesis of polyphosphazenes  from 
hexachlorocyclotriphosphazene (1a) via the thermal ring opening polymerization 
method.15 
Despite the success of this reaction, researchers have explored other ways of forming 
linear poly[(dichloro)phosphazene] in order to overcome some of the limitations of the 
thermal ring opening polymerization since it requires specialized equipment, the use of 
extreme temperatures, and high purity of the starting trimer. 
2.3.1.2 Thermal Ring Opening Polymerization – Solution Phase 
In 1990, Magill and co-workers71 developed a new solution phase ring opening 
polymerization method for the synthesis of poly[(dichloro)phosphazene], which 
eliminated the need for a specialized oven that allowed for continuous rocking of the 
sample throughout the reaction.  Also, the new Magill method substantially decreased the 
reaction time from 5 days down to roughly one hour.  The Magill method used a three-
neck round bottom flask as the reaction vessel, which allowed for the attachment of a 
reflux condenser and a gas inlet for N2 bubbling (to protect the hydrolytically sensitive 
polymer from moisture).  In their method, they dissolved the trimer in 1,2,4-
trichlorobenzene and added small amounts of sulfamic acid (HSO3(NH2)) and calcium 
sulfate dihydrate (gypsum, CaSO42 H2O) as catalyst and promoter, respectively 
(Scheme 2.2).  They allowed the mixture to react at reflux with dry N2 bubbling and 
stirring until the solution was sufficiently viscous, which was approximately 45 to 60 
minutes depending on the experiment.  The experimenter needed to be attentive to the 
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reaction because if it was allowed to proceed beyond this point crosslinking occurred and 
the linear poly[(dichloro)phosphazene] was no longer useful as it was insoluble. They 
obtained yields of approximately 35% using this method.  A major drawback of this 
method over the bulk polymerization is that it uses solvents, which are expensive and can 
be problematic for biocompatibility if they are not fully removed prior to cell seeding and 
implantation, and the necessity of the experimenter to be ever present, unlike the bulk 
phase TROP that can be controlled by a self-timed oven. 
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Scheme 2.2: Reaction scheme for the solution phase thermal ring opening 
polymerization of hexachlorocyclotriphosphazene (cyclic trimer) to linear 
poly[(dichloro)phosphazene] using a sulfamic acid catalyst and calcium sulfate 
dehydrate promoter – The Magill Method. 
2.3.1.3 “Living” Cationic Polymerization 
Polymerization methods that do not rely on the thermal ring opening of 
hexachlorocyclotriphosphazene have also been reported in the synthesis of 
poly[(dichloro)phosphazene].72-80 In 1995, Allcock and co-workers 75 proposed a room 
temperature synthesis of linear poly[(dichloro)phosphazene] that overcame the obstacle 
of high temperature synthesis experienced with the previously described ring opening 
polymerization, both in the bulk and solution phase.  In their research, they developed a 
synthesis of poly[(dichloro)phosphazene] from the phosphorus pentachloride (PCl5) 
initiated polycondensation of trichlorotrimethylsilylphosphoranimine (Cl3P=NSiMe3). 
This reaction proceeded with trace amounts up to 2 equivalents of PCl5 initiator for every 
1 equivalent of Cl3P=NSiMe3, leading to the elimination of trimethylsilyl chloride 
(Me3SiCl) as a by-product (Scheme 2.3). The use of trace amounts of PCl5 allowed for 
quantitative conversion of the monomer to linear poly[(dichloro)phosphazene], although 
preparing reaction mixtures with specified equivalents of initiator to monomer increased 
the molecular weight of the resultant poly[(dichloro)phosphazene], with 2 equivalents of 
PCl5 to every 1 equivalent of Cl3P=NSiMe3 producing the highest molecular weight 
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product.  In bulk phase preparation, freshly distilled Cl3P=NSiMe3 and trace PCl5 were 
reacted via a heterogeneous reaction in an evacuated, heat-sealed Pyrex tube, similar to 
those used for the bulk phase thermal ring opening polymerizations previously discussed, 
at room temperature over 24 hours.70  Molecular weight control proved challenging in 
bulk phase polymerization, even as the ratio of initiator to monomer was varied, leading 
the researchers to look into solution phase polycondensation polymerization. In solution 
phase preparation, PCl5 was added to a solution of Cl3P=NSiMe3 dissolved in 
dichloromethane (DCM) under nitrogen.  The mixture was stirred and allowed to react 
for 24 hours at 25°C.  The proposed reaction mechanism of the “living” cationic 
polymerization is presented in Scheme 2.4. The polycondensation reaction described 
above has also been studied in numerous other solvents to determine solvent effects and 
reaction kinetics.72, 73 Although the reaction times of the polycondensation of 
Cl3P=NSiMe3 are much less than those used in bulk thermal ring-opening 
polymerizations, they require the use of PCl5 which is a highly moisture sensitive 
compound that reacts violently with water and poses a potential safety concern.  Also, the 
hydrolysis of PCl5 leads to the formation of hydrogen chloride (HCl), which could cause 
problems with cell viability, as in the case of polymers that hydrolyze into acidic by-
products, if the starting material is not reacted completely and remains in the product due 
to insufficient purification.81 
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Scheme 2.3: Reaction scheme for the phosphorus pentachloride (PCl5) initiated bulk 
and solution phase polycondensation of trichlorotrimethylsilylphosphoranimine 
(Cl3P=NSiMe3) to poly[(dichloro)phosphazene] ([NPCl2]n) – The “Living” Cationic 
Polymerization Method. 
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Scheme 2.4: Proposed cationic polymerization step-wise mechanism of the PCl5 
initiated polycondensation reaction of Cl3P=NSiMe3 to [N=PCl2]n. 
2.3.1.4 One-Pot De Jaeger Polymerization 
In the early 1980s, De Jaeger and co-workers79, 80 developed an alternative route to 
poly[(dichloro)phosphazene] ([NPCl2]n) using trichloro-N-(dichlorophosphoryl)-
monophosphazene (Cl3P=NP(O)Cl), rather than the standard thermal ring opening 
polymerization.  In their synthesis, Cl3P=NP(O)Cl monomer is reacted in the bulk 
through a thermal polycondensation reaction that releases P(O)Cl3 (Scheme 2.5).  This 
reaction is performed in a three-neck reaction vessel with a dry nitrogen gas inlet, 
motorized stirring, and two condensers (one with oil cooling at 130°C and the other with 
traditional water cooling).  The monomer was added to the vessel at 245°C and allowed 
to react for approximately 18 hours, at which point trichlorobiphenyl was added as a 
solvent to decrease the viscosity of the reaction mixture and improve the conversion of 
the monomer to poly[(dichloro)phosphazene]. The reaction mixture dissolved in 
trichlorobiphenyl was allowed to react for up to another 34 hours at 276°C. It is not well 
documented how the poly[(dichloro)phosphazene] polymer is collected from the reaction 
solution, although it is presumed that the solution was concentrated under reduced 
pressure and the polymer was reprecipitated with a miscible non-solvent.  This method 
gives almost quantitative conversion of the monomer to linear 
poly[(dichloro)phosphazene] and an easily removable P(O)Cl3 byproduct. Drawbacks of 
this reaction are the requirement to synthesize the monomer prior to its use in the 
polycondensation, which is time consuming and synthetically demanding.  The monomer 
must also be extremely pure to ensure that the polymerization is successful. Furthermore, 
the addition of the trichlorobiphenyl solvent is not ideal for the development of 
biomaterials as it is highly toxic and may cause organ damage, and therefore if any 
remains in the material following purification it is likely to be cytotoxic.  Another 
deterrent from using trichlorobiphenyl solvent is that it is extremely expensive, which is 
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not ideal if the ultimate intention is for these materials to be scaled-up for use in the 
development of clinically viable tissue-engineered grafts. 
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Scheme 2.5: Reaction scheme for the synthesis of poly[(dichloro)phosphazene] from 
the polycondensation reaction of Cl3P=NP(O)Cl2 – The De Jaeger Method. 
Overall, the thermal ring opening polymerization involves the least synthetic chemistry 
and has the fewest by-products and potential solvent contaminants, which is ideal for 
materials intended for biomedical applications. Therefore, a facile thermal ring opening 
polymerization that does not require expensive equipment like rocking machinery within 
the oven or the use of a glovebox would be ideal in synthesizing polyphosphazenes for 
biomedical applications such as tissue engineering.    
2.3.2 Macromolecular Substitution of Poly[(dichloro)phosphazene] with Organic 
Nucleophiles 
Once high molecular weight linear poly[(dichloro)phosphazene] is synthesized, the 
polymer can be modified by substituting the phosphorus-bound chlorine atoms with 
organic side groups.  The polymer undergoes a macromolecular substitution (Scheme 
2.1, reaction of compound 1b into four potential polyphosphazene structures) when 
subjected to organic and organometallic nucleophiles, forming a large class of 
polyphosphazenes as shown in Figure 2.2.66, 67 All of the polyphosphazenes shown in 
Figure 2.2 have one type of side chain throughout the entire polymer, although it has 
been shown that developing co-substituted materials with well-defined ratios of side 
chains are possible by controlling the amount and order of addition of the nucleophiles.67, 
68, 82 The modification of type and ratio of the side chains of the polymer affords the 
ability to fine-tune degradation rates and physical properties based on these substituents, 
which is key to the synthesis of a biomaterial suitable for tissue engineering and 
therapeutic delivery.83  
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The main substitution method for amino acid esters that has been described in the 
literature entails a two-step reaction in which the free base of the amino acid is generated 
prior to substitution by reacting the amino acid ester hydrochloride salt with a non-
nucleophilic base, typically triethylamine (TEA, NEt3).12, 15, 55, 67, 83-94  Harry Allcock and 
co-workers, the largest players in the field of poly(organophosphazene)s, developed this 
method in the 1970s, and have been using it ever since.95  In their synthetic scheme, the 
amino acid ester hydrochloride salt is suspended in anhydrous tetrahydrofuran (THF, b.p. 
66°C) with an excess of TEA and allowed to reflux with stirring for 24 hours.  The 
reaction mixture is then filtered and the filtrate is added to a flask containing 
poly[(dichloro)phosphazene] dissolved in anhydrous THF. This mixture is allowed to stir 
for an additional 48 hours at room temperature until complete substitution has been 
achieved.  When preparing co-substituted poly[(amino acid ester)phosphazene]s, the 
same general procedure is followed to initially prepare the free bases of the amino acid 
esters although the substitution reaction is somewhat modified.  In that case, the more 
bulky substituent is added first in stoichiometric amounts and allowed to react for a given 
time, based on the reactivity of the specific substituent, with the 
poly[(dichloro)phosphazene] precursor.83  Next, the second substituent is added in excess 
to react at the remaining P-Cl bonds until the polymer is fully substituted.  After 
substitution of either the mono-substituted polyphosphazene or co-substituted 
polyphosphazene is complete, the product is precipitated from the THF reaction solution 
using anhydrous hexanes.  This process is repeated two additional times to remove the 
by-products and excess starting materials.  The polymer is then occasionally purified 
further using cellulose membranes of specific molecular weight cutoffs. All of the 
aforementioned reactions and purification procedures are performed under moisture free 
conditions in either a glovebox or under dry nitrogen gas using standard Schlenk line 
techniques.  Considering the requirement of advanced equipment, like a glovebox, 
making the polymers in this fashion is limited to researchers with access to these 
expensive pieces, which are not always available or are out of the budget, thus limiting 
research into novel polyphosphazene materials, which are suitable for biomedical 
applications, to research groups with access to this equipment and hindering the progress 
of the field as a whole. 
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Along with the reflux and room temperature mixing two-step substitution reaction 
described above, Allcock and co-workers also investigated the success of a two-step 
reaction at low temperatures as well.95 In the low temperature synthetic scheme, the 
amino acid ester hydrochloride salt was reacted with excess triethylamine in refluxing dry 
benzene for 3.5 hours, at which point it was cooled and filtered.  In a separate flask, 
poly[(dichloro)phosphazene] was dissolved in dry benzene and cooled to 0°C.  The 
filtrate containing the free base of the amino acid ester was then added to this mixture 
drop-wise and the solution was allowed to stir for an additional 6 hours at 0°C, followed 
by 10 hours at room temperature.  The final solution was filtered to remove insoluble 
salts and the solution was concentrated by rotary evaporation.  The substituted polymer 
was collected as a solid by precipitation with n-heptane.  This process of dissolution in 
benzene and repricipitation in n-heptane was performed twice more to satisfactorily 
purify the polymer. Another low temperature substitution method was studied by 
Parnigotto and co-workers,77, 78 which used THF as the solvent rather than carcinogenic 
benzene and was successful in the synthesis of poly[(amino acid ester)phosphazene]s. An 
adapted two-step low temperature substitution was attempted in this work based on the 
low temperature variations reported in the literature.    
2.4 Suitability of Polyphosphazene Biomaterials  
In order for polyphosphazenes to be considered a suitable biomaterial they must be 
compatible with the biological environment they are intended to interact with.2, 15, 96 They 
must also be either biostable or biodegradable into non-toxic degradation products. 
Bioerodible biomaterials are usually preferred since they leave only the natural tissue 
once the material has degraded, eliminating the long-term risk of immune response and 
potential negative outcomes.2, 5, 13, 83-85, 88, 91, 93, 97-101 Lastly, the biomaterial must have 
mechanical properties that match or closely resemble those of the natural tissue so that 
issues such as compliance mismatch, a common problem, for example, in vascular tissue 
engineering, are reduced.96, 102 In the next few sections, the current understanding 
regarding the biocompatibility, biodegradation, and mechanical properties of 
polyphosphazenes biomaterials is summarized.  This section will focus on the suitability 
of polyphosphazenes, mainly poly[(amino acid ester)phosphazene]s, as biomaterials due 
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to their unique tunability of degradation and mechanical properties and non-toxic 
degradation products, making them useful in a wide range of biomedical applications 
including tissue engineering.12, 15, 68  
2.4.1 In Vitro and In Vivo Biocompatibility 
The cytocompatibility of amino acid ester functionalized polyphosphazene biomaterials 
was first studied by Laurencin et al.88 who compared rat primary osteoblast adhesion to 
poly[(ethyl glycinato)phosphazene] (PNEG) with well-known poly(lactic acid-co-
glycolic acid) (PLAGA) and poly(anhydrides).    Data from this study showed that the 
osteoblast cells adhered to the PNEG material to the same extent as the control materials 
for a period of 8 hours. The degradation of PNEG did not influence cell proliferation as it 
promoted cell growth to the same extent as the PLAGA control material.  In a follow-up 
study89, similar experiments on other ethyl glycinato/methyl phenoxy co-substituted 
polyphosphazenes using MC3T3-E1 cells (osteoblast precursor cell line from mice) were 
conducted.  The results from this study also suggested that cells responded favourably to 
polyphosphazene materials, especially those with a high ratio of ethyl glycinato 
substituents, and that cell adhesion and proliferation characteristics were not diminished 
in comparison to tissue culture plate and PLAGA controls.  The polymers with 50% and 
greater of ethyl glycinato substituents demonstrated improved cell growth in comparison 
to the tissue culture plate and the polymer with 25% ethyl glycinato substitution was only 
slightly less efficient than the tissue culture plate, although all of these were better than 
the PLAGA control, which has been widely accepted as a biocompatible material.  
Studies on co-substituted amino acid ester based polyphosphazenes containing an ethyl 
alanato substituent along with aryloxy substituents such as poly[(ethyl alanato)1(ethyl 
oxybenzoate)1 phosphazene] (PNEAEOB) and poly[(ethyl alanato)1(propyl 
oxybenzoate)1phosphazene] (PNEAPOB) demonstrated that  neither PNEAEOB nor 
PNEAPOB posed a threat to cell growth, in comparison to the controls, as both materials 
were capable of promoting cell adhesion and proliferation.93 Collectively, the results of 
the above studies from the Laurencin laboratory are promising since cell adhesion and 
proliferation are not affected in comparison to materials that have previously been 
extensively studied for their effect on cell viability.   
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Gumusderelioglu and Gur103 performed a study that investigated the cytotoxicity of 
poly[bis(ethyl-4-aminobutyro)phosphazene] by analyzing the activity level of succinic 
dehydrogenase (SDH) through an MTT assay method.  SDH plays a critical role in 
cellular metabolism and is therefore a good indicator of cytotoxicity.104 For these 
experiments extracts collected from the incubation of the polymeric films with growth 
medium were added to 3T3 and HepG2 cells. For the negative control, extracts were 
collected from a polyethylene centrifuge tube that was incubated with the growth medium 
but lacked a sample of polymeric film.  It was shown that poly[bis(ethyl-4-
aminobutyro)phosphazene] extracts did not significantly decrease cell viability in Swiss 
3T3 and HepG2 cells in comparison to negative controls.  The material maintained cell 
viability, as demonstrated by SDH activity level, greater than 80% of that of the control 
for all time points and for both cell types.  This study was successful in showing the 
cytocompatibility of the material with respect to 3T3 and HepG2 cells, which are 
commonly used cell lines to study fibroblast and hepatocyte biology, respectively. The 
cytocompatibility of electrospun matrices of co-substituted poly[(amino acid 
ester)phosphazene]s towards rat endothelial cells was investigated by Carampin and co-
workers.105 They studied poly[(ethyl phenylalanato)1.4(ethyl glycinato)0.6phosphazene] 
for both cell adhesion and growth properties in comparison to a fibronectin-coated 
polystyrene tissue culture plate as the control.  They found that the polymer only slightly 
improved cell adhesion (7% increase) in comparison to the culture plates, but that the 
polymer enhanced growth of the adhered cells by approximately 17%.  These results 
reinforced the notion that polyphosphazenes could act as a biocompatible material for use 
in biomedical applications such as tissue engineering.   
All of the aforementioned studies involved only in vitro analyses of the cytocompatibility 
of the polyphosphazenes despite the fact that their end goal is to be used as a biomaterial 
in vivo. Towards this end, in vivo studies of alanine-modified polyphosphazenes on rat 
and rabbit models for bone tissue engineering materials have been reported.15, 93 In the rat 
model93, subcutaneously implanted samples were monitored for biocompatibility through 
immune response. Inflammatory responses were categorized as minimal, mild, or 
moderate based on the accumulation of immune response cells (e.g. neutrophils/PMNs 
and lymphocytes) at the implantation site.  It was observed that at two weeks post 
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implantation, [poly(ethyl alanato)phosphazene] (PNEA) induced a moderate 
inflammatory response that initially decreased to minimal at four weeks but then slightly 
increased to mild at 12 weeks.  As for poly[(ethyl alanato)1(p-methyl 
phenoxy)1phosphazene] (PNEAmPh), the material caused a moderate inflammatory 
response at two weeks, which gradually decreased to a minimal response after 12 weeks. 
The poly[(ethyl alanato)1(p-phenyl phenoxy)1phosphazene] (PNEAPhPh) material 
elicited a mild initial response at two weeks, which slowly decreased to a minimal 
response at 12 weeks. Overall, the inflammatory responses for the PNEAmPh and 
PNEAPhPh were minimal suggesting that the materials are suitable for bone tissue 
engineering.  The PNEA material triggered a greater inflammatory response than the two 
co-substituted polyphosphazenes although the response decreased over the time span of 
the study suggesting that, it too, is a good candidate.  All three materials elicited immune 
responses that were acute and did not pose a long-term threat to the animals.   
The potential utility of polyphosphazenes is not limited to bone tissue engineering. 
Langone et al.106 conducted in vivo biocompatibility of polyphosphazenes as tubular 
nerve guides in rat models.  Comparative studies of   poly[(ethyl alanato)1.4(imidazolyl)0.6 
phosphazene] (PNEAIL) nerve guides with traditional biostable silicone guides suggested 
the absence of inflammatory response to the polyphosphazene material after 30 and 60 
days of implantation.  Upon removal of the implanted nerve guide, it was noted that the 
stumps of the rat sciatic nerve, which had initially been transected, had reattached with 
components comprised primarily of nerve fiber bundles, akin the natural nerve tissue.  
This in vivo study suggested that PNEAIL was a biocompatible material, especially for 
use in nerve regeneration strategies, and highlights its potential utility in the future. 
2.4.2 Biodegradability 
Since it is desirable to use biodegradable biomaterials for tissue engineering and delivery 
of therapeutics many research groups have studied the degradation properties of 
polyphosphazenes.13, 84, 85, 91, 93, 97, 98, 100, 101, 107 Polyphosphazenes are attractive because 
they have been shown to degrade into non-toxic by-products that are easily metabolized 
by the body.  In the case of an amino acid ester phosphazene, these hydrolytic 
degradation products include the amino acid, the corresponding alcohol of the ester, 
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ammonia, and phosphates.84 Unlike the acidic products produced from the hydrolysis of 
other polymers, the ammonia and phosphates act as a buffering system and prevent 
fluctuations in pH, which could otherwise be detrimental to the tissue.108  Although the 
exact mechanism of degradation is not known, there are several pathways that have been 
proposed.84 Overall, the first two steps of the degradation result in the hydrolysis of the 
ester of the amino acid, forming an alcohol, and detachment of the amino acid from the 
polyphosphazene backbone forming the amino acid itself.  The backbone of the 
polyphosphazene is then hydrolyzed to phosphates and ammonia.  The formation of 
phosphates during the degradation process was verified through the addition of silver 
nitrate or zirconyl chloride, which forms a yellow silver phosphate or white zirconyl 
phosphate precipitate, respectively.84 The amino acids and ammonia degradation products 
can be demonstrated by ninhydrin test, which detects ammonia, primary, and secondary 
amines, whereas as 1H nuclear magnetic resonance (NMR) spectroscopy can be utilized 
for detecting alcohols. 
Another important factor with regards to biodegradability is the rate at which the material 
degrades since this can limit potential applications.  It is important when designing a 
scaffold that the material degrades at a rate that is similar to the rate of tissue growth or 
therapeutic release rate depending on the application.  For tissue engineering, if the 
scaffold material degrades too quickly there will be insufficient support for the 
underdeveloped tissue and mechanical weakness will ensue.  If the material degrades too 
slowly or not at all, it may need to be surgically removed, which could in turn damage the 
neo-tissue and cause problems with mismatched mechanical properties relative to the 
natural tissue.35 In order to determine the degradation rates of poly[(amino acid 
ester)phosphazene]s, the influence of changing the types and ratios of side chain 
substituents on the degradation properties of the polymers is an important factor. Table 
2.1 provides an overview of the degradation studies that have been performed on 
polyphosphazenes substituted with amino acid esters and other co-substituents.  
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Table 2.1: Summary of in vitro degradation studies of poly[(amino acid 
ester)phosphazene]s and their co-substituted polyphosphazenes. The ester refers to 
the chain attached to the carboxyl terminus of the amino acid. The detailed 
degradation profiles can be found in the cited references. 
 
In view of this, the degradation rates of poly[(amino acid ester)phosphazene]s with 
different amino acids and different esters of the amino acids were studied in solution- and 
solid-state, although solid-state degradation is more representative of how degradation 
would occur with in vivo scaffold materials and is the method that will be discussed.84 
The effect of changing the ester group was investigated using glycine based poly[(amino 
acid ester)phosphazene]s including poly[bis(methyl glycinat-N-yl)phosphazene] 
(PNMG), poly[bis(ethyl glycinat-N-yl)phosphazene] (PNEG), poly[bis(tert-butyl 
glycinat-N-yl)phosphazene] (PNtBG), and poly[bis(benzyl glycinat-N-yl)phosphazene] 
(PNBzG).  In this systematic study, the molecular weight decline was in the order of 
PNBzG < PNtBG < PNEG < PNMG, with PNMG having the greatest decrease in 
molecular weight.  This showed that as the hydrophobicity of the ester group increased 
(from methyl to benzyl), the molecular weight decline of the polymer decreased.  The 
decreased molecular weight decline is due to the inability of water to approach the 
polymer due to its hydrophobicity, and therefore the hydrolysis of the material is 
hindered.  The effect of changing the amino acid using poly[bis(methyl glycinat-N-
yl)phosphazene] (PNMG), poly[bis(methyl alaninat-N-yl)phosphazene] (PNMA), 
poly[bis(methyl valinat-N-yl)phosphazene] (PNMV), and poly[bis(methyl 
phenylalaninat-N-yl)phosphazene] (PNMF) showed that the molecular weight decline 
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increased on the order of PNMF < PNMV < PNMA < PNMG.  This trend was observed 
since the hydrophobicity of the polymer increased as larger non-polar side chain amino 
acids, like phenylalanine, were incorporated into the polyphosphazene.  This study was a 
good initial demonstration of the biodegradability and hydrolysis properties of different 
poly[(amino acid ester)phosphazene]s, although a more suitable degradation medium 
would be phosphate buffer solution (PBS) at 37°C, which is more representative of the 
body fluid pH, temperature, and ion concentrations.   
The effect that types of side groups had on the degradation rates of L-alanine co-
substituted polyphosphazenes, specifically PNEA, poly[(ethyl alanato)1(ethyl 
glycinato)1phosphazene] (PNEAEG), PNEAmPh, and PNEAPhPh was also reported in a 
separate study.83 As may be expected the ethyl glycinato substituted phosphazene 
(PNEAEG) had the fastest molecular weight decline, where as the biphenyl substituted 
phosphazene (PNEAPhPh) had the slowest molecular weight decline.  The PNEAEG 
material hydrolyzed so quickly that molecular weight could not be evaluated beyond 
week two of the degradation study. It was noted that the pattern of molecular weight 
decline showed a quicker degradation rate for the smaller, more hydrophilic substituent 
polymers as compared to those substituted with large bulky hydrophobic substituents.  
Compared to imidazolyl side groups, increasing the amount of ethyl glycinato groups 
increased the degradation rate of the polymer, indicating that the incorporation of less 
sterically hindered, more hydrophilic groups causes the polymers to degrade more 
quickly.89 The results of the study were successful in demonstrating the tunability of 
degradation properties of co-substituted polyphosphazenes, which is a key requirement in 
the development of a biomaterial for tissue engineering applications. Overall, this study 
effectively showed the ability to tune degradation rates of poly[(amino acid 
ester)phosphazene]s through careful selection of side group substituents. In vivo 
degradation studies showed substantial decline in molecular weight for the PNEA and 
PNEAmPh implants after 12 weeks, 80% and 98%, respectively.93 PNEAPhPh, on the 
other hand, did not experience as great of a molecular weight decline as the other two 
implants and had a molecular weight decline of only 63% after 12 weeks.  This is 
presumably due to the increased hydrophobicity of the biphenyl substituent, which limits 
the approach of water to the polymer backbone and therefore slows its hydrolysis. This 
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study proves the in vivo biodegradability of poly[(amino acid ester)phosphazene]s, as 
well as their biocompatibility.  The results of this study should be taken with caution 
since the implant in this cited study was designed for bone tissue engineering applications 
and as such, it is implanted into a region of the rat where bone tissue is the predominant 
tissue type.  Naturally occurring enzymes, which have the potential to significantly 
influence degradation rates if they recognize the materials, have different abundances 
across different types of tissues.  Therefore, if the poly[(amino acid ester)phosphazene]s 
investigated in this study are to be applied to other tissue engineering applications, such 
as vascular tissue engineering, their degradation rates in those tissues may vary 
dramatically from those presented here due to differences in enzymatic degradation.  The 
relative abundance of water in a tissue also determines rates of hydrolysis and the 
materials could therefore show significantly different hydrolytic degradation rates in 
different tissues. 
Other studies were conducted on the effects of changing ratios of substituents on the 
degradation rates of the polymers.99 Mass loss measurements following PBS incubation 
focused on co-substituted polyphosphazenes of ethyl 2-(O-glycyl)lactate and ethyl 
glycinate. Decreasing the ratio of ethyl glycinate: ethyl 2-(O-glycyl)lactate, for materials 
with varying side chain ratios between 100% ethyl glycinate: 0% ethyl 2-(O-
glycyl)lactate to 75% ethyl glycinate: 25% ethyl 2-(O-glycyl)lactate, increased the mass 
loss rate of the polymer.  This is due to the increased hydrolytic sensitivity of ethyl 2-(O-
glycyl)lactate, in comparison to ethyl glycinate, which encourages polymer degradation 
and therefore mass loss as well.  Even though mass loss is not a direct indication of 
molecular weight decline83, it is still a good indicator of the relative degradation rates of 
the polymers and as such, it can be approximated that polymers with a higher ratio of 
ethyl glycinato substitution degrade less quickly than those with increased levels of ethyl 
2-(O-glycyl)lactate.  This study was useful in demonstrating the effect that varying ratios 
of substituents with different hydrolysis-sensitivities and solvation properties has on the 
degradation rates of the polymers, which can be useful for tailoring degradation 
properties of co-substituted polyphosphazenes according to their specific biomedical 
applications.  
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Taken together, these studies have been able to demonstrate not only that poly[(amino 
acid ester)phosphazene]s are biodegradable, but also that their degradation rates can be 
tuned by changing a variety of factors, such as type and ratio of side groups. The fact that 
bioerodability studies have been performed in vitro in body fluid simulating solutions and 
in vivo in rat models suggests that these polyphosphazene materials are suitable for use in 
tissue engineering applications such as scaffold biomaterials as well as for other 
biomedical applications that require the use of degradable materials. 
2.4.3 Mechanical Properties 
In order to produce clinically viable tissue engineered products, the mechanical properties 
of the constructs must match the properties of the natural tissues.  If the mechanical 
properties, such as compressive strength and tensile strength, are not comparable to those 
of native tissues, problems with mismatch arise which often lead to failure of the tissue-
engineered construct.109-112 There have been only a limited number of studies carried out 
to investigate the mechanical properties of poly[(amino acid ester)phosphazene] 
materials. One such study was conducted by Sethuraman et al.94 who investigated the 
mechanical properties of alanine-based polyphosphazenes for their application as bone 
tissue engineering biomaterials.  For these studies polyphosphazenes were compared with 
the current standard for bone tissue engineering applications, PLAGA (85% lactic 
acid:15% glycolic acid).  Cylindrical discs of each polymer were initially subjected to a 
compressive force of 1500 pounds per square inch (psi) for 15 min and analyzed using a 
uniaxial compressive testing instrument set with the following parameters, 500N load cell 
and 10 mm/min compression rate, until material failure. The compressive strengths of 
PNEA and PNEAmPh were comparable to that of PLAGA (34.9 ± 5.7 MPa), with 
compressive strengths of 46.61 ± 17.56 MPa and 24.98 ± 11.26 MPa, respectively.  
PNEAPhPh on the other hand had a compressive strength that was significantly higher 
than that of PLAGA due to the large aromatic groups increasing steric bulk and 
decreasing torsion of the polymer backbone. Together these increase the rigidity of the 
material and modulate its compressive properties.  Therefore, it can be noted that the 
mechanical properties, like the degradation properties, of polyphosphazene materials can 
be tailored based on their proposed applications by changing the side group substituents. 
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The tensile strength and elasticity of several L-alanine based polyphosphazene materials 
(namely, PNEAEG, PNEA, PNEAmPh, and PNEAPhPh) were determined using micro-
tensile testing techniques.94 It was shown that increasing the steric bulk of the co-
substituent increased both the tensile strength and elasticity of the material with more of 
an impact being observed as the side chain is changed from a small amino acid such as 
glycine or alanine ethyl ester, such as in PNEAEG and PNEA, to large aromatic 
substituents, such as in PNEAmPh and PNEAPhPh.  This is because introducing large 
aryloxy substituents affects the glass transition temperature and molecular weight of the 
polymer, which in turn affects the mechanical properties of the material.  Overall, this 
study shows how the mechanical properties of a polyphosphazene material can be 
tailored simply through co-substitution of large aromatic groups alongside amino acid 
esters. 
Both of the above studies showed that changing the types and ratios of side group 
chemistries of polyphosphazene materials can modulate mechanical properties, such as 
compressive strength, tensile strength, and elasticity. Therefore, the mechanical 
properties of these materials can be tuned to suit the intended application, making 
polyphosphazenes useful as biomaterials in a wide range of different biomedical 
applications.  One concern here is that changing the side groups not only affects 
mechanical properties but also degradation rates and therefore adapting the side chains to 
obtain suitable mechanical properties may cause the degradation rate of the material to be 
either too fast or too slow for the application, which is undesirable.  As such, it is 
suggested that research into other methods to control mechanical properties that do not 
influence erosion properties should be developed.  For example, it may be useful to 
investigate the effects of different processing methods or scaffold preparation techniques 
(e.g. electrospinning versus solvent casting and particulate leaching) on mechanical 
properties.   
2.5 Objectives and Rationale 
As was shown in the preceding literature review, poly(organophosphazene)s have been 
studied extensively for their use in many biomedical applications, including tissue 
engineering.  To date, the majority of research surrounding poly[(amino acid 
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ester)phosphazene]s focuses on orthopedic tissue engineering and drug delivery 
applications with limited use in vascular tissue engineering.87-89, 93, 94, 113  A potential 
reason as to why these materials have been limited to mainly bone applications is that the 
synthesis of the precursor material (poly[(dichloro)phosphazene]) requires either 
extensive chemical synthesis and/or expensive specialized equipment before the actual 
poly[(amino acid ester)phosphazene] materials can be realized. By optimizing a thermal 
ring opening synthesis process that requires less harsh reaction conditions and fewer 
costly pieces of machinery, thus making it more accessible to researchers like ourselves, 
poly[(amino acid ester)phosphazene]s may be investigated for other biomedical 
applications, including vascular tissue engineering.  It is also hoped that the substitution 
of poly[(dichloro)phosphazene] with organic nucleophiles can be simplified into a one-
pot reaction and eliminate the necessity of liberating the free base of the amino acid ester 
at elevated temperatures prior to reaction.  Once these two techniques are developed, it is 
proposed that they will be used to synthesize novel co-substituted poly[(amino acid 
ester)phosphazene]s that incorporate amino acids that have functional side chains (e.g. 
glutamic acid, aspartic acid, and lysine) and can be used for further surface modification 
of the materials.  The functional handles that will be made available through the 
deprotection of the side chains will allow for the conjugation of biomolecules that are 
known to enhance cell-material interactions, which is ideal in developing biomaterials for 
scaffolds.  Lastly, considering that scaffolds are required to have a 3-D configuration for 
vascular graft formation, electrospinning of the poly[(amino acid ester)phosphazene]s 
should be investigated. 
      In view of the above rationale, the objectives of this work were to: 
 Develop a facile polymerization technique and compare substitution methods for 
the synthesis of poly(amino acid ester)phosphazenes 
 Prepare the benzyl side chain protected glutamic acid ethyl ester via esterification 
and deprotection 
 Synthesize and characterize (FTIR, NMR, TGA, DSC, and GPC) a family of non-
functional and functional poly[(amino acid ester)phosphazene]s  
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o Non-functional amino acid ethyl esters: alanine, phenylalanine, 
methionine  
o Functional amino acid ester: benzyl side chain protected glutamic acid 
ethyl ester 
 Evaluate cytotoxicity of functional and non-functional poly[(amino acid 
ester)phosphazene]s on 2-D films 
 Fabricate a polyphosphazene-based 3-D non-woven fibrous mat via 
electrospinning 
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Chapter 3  
3 Materials and Methods 
3.1 Thermal Ring Opening Polymerization (TROP) 
3.1.1 Materials 
The hexachlorocyclotriphosphazene cyclic trimer was purchased from Sigma Aldrich 
(Milwaukee, WI) and Alfa Aesar (Ward Hill, MA).  Anhydrous tetrahydrofuran (THF), 
glass distilled hexanes-190, 2-propanol (iPrOH), reagent grade hydrochloric acid (HCl), 
and potassium hydroxide (KOH) were obtained from Caledon Labs (Georgetown, ON).  
Krytox Performance Lubricant GPL207 high temperature grease was acquired from 
DuPont (Wilmington, DE).  All chemicals and solvents were used as received without 
further purification.   
3.1.2 Equipment 
The polymerizations were performed in a VWR Symphony Horizontal Air Flow Oven 
(50L, 1.75cuft, 120V, 60Hz) purchased from VWR International (Radnor, PA). The glass 
reaction vessels and stainless steel vial rack shown in Figure 3.1 were manufactured by 
the glass blowing and engineering machine shops at The University of Western Ontario 
(London, ON), respectively.  
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Figure 3.1: The glass vials and stainless steel vial rack that were manufactured in-
house for the facile thermal ring opening polymerizations. The schematic on the 
right side shows approximately dimensions of the glass vials and stoppers used as 
the reaction vessels. 
3.1.3 Method 
The polymerizations were performed in batches of three reaction vessels, with each 
reaction vessel containing approximately 1.06g (3.05mmol, 1.0 equiv) of 
hexachlorocyclotriphosphazene.  The vessels were prepared by weighing the trimer into 
the glass vial, lubricating the glass stopper with sufficient Krytox grease, and sealing the 
vial with the glass stopper.  The vessels were then placed in a line in the vial rack and the 
rack was inserted into the preheated high temperature oven set at 230 °C with the vessels 
spanning from left to right in the oven and the rack being positioned approximately in the 
center of the oven.  The optimized reaction scheme for the ring opening polymerization is 
presented in Scheme 3.1. A programmable timer on the oven was used to control the 
length of the reaction, where the oven would stop heating and would cool to room 
temperature after the specified time. It took approximately 6 minutes for the oven to cool 
to temperatures below 200 °C, which was likely too cool for polymerization to occur. 
Once the oven had cooled, the samples were removed from the oven and scrapped from 
the inside of the vials into a 50mL centrifuge tube, where they were then purified by 
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dissolving the product in minimal anhydrous THF and reprecipitating the polymer in 
hexanes.  The crude product dissolved in anhydrous THF was filtered to remove 
insoluble impurities prior to repricipitation with hexanes.  This dissolution/reprecipitation 
process was repeated three times. The poly[(dichloro)phosphazene] (PDCP) material is 
highly reactive and cannot be dried completely due to its quick decomposition when 
overnight drying under vacuum was attempted. This was also presumably due to rapid 
hydrolysis of the material upon exposure to even atmospheric moisture and therefore the 
material must be used in a substitution reaction immediately after its purification. 
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Scheme 3.1: Reaction scheme for the facile thermal ring opening polymerization 
(TROP) of hexachlorocyclotriphosphazene to linear poly[(dichloro)phosphazene] 
(PDCP).  
After recovery of the PDCP product and in between polymerizations, the glass reaction 
vessels were cleaned using a base bath, water rinse, acid bath, water rinse, and drying 
method to remove any residual polymer or grease. The base bath used was a concentrated 
solution of KOH in 50/50 mixture of iPrOH and deionized (DI) H2O.  The acid bath was 
a concentrated solution of HCl in DI water.  Typically, the reaction vessels were allowed 
to soak in the base bath overnight, were rinsed with DI water, and were scrubbed clean 
using a small wire scrub brush. The vessels were then rinsed with more DI H2O and 
allowed to soak in the acid bath for a minimum of 2 hours.  Upon removal from the acid 
bath, the vials were rinsed with DI H2O one final time and were dried in a drying oven 
prior to their re-use.  
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3.2 Macromolecular Substitution of Non-Functional Amino Acid 
Esters 
3.2.1 Materials 
Anhydrous THF and glass-distilled hexanes were again acquired from Caledon Labs. All 
non-functional amino acid esters, L-alanine ethyl ester hydrochloride (H-Ala-OEtHCl), 
L-phenylalanine ethyl ester hydrochloride (H-Phe-OEtHCl), and L-methionine ethyl 
ester hydrochloride (H-Met-OEtHCl), were from Alfa Aesar (Ward Hill, MA). 
Triethylamine (NEt3) was purchased from Sigma Aldrich. The 
poly[(dichloro)phosphazene] (PDCP) material was obtained from the thermal ring 
opening polymerization described above.  All chemicals and solvents were used as 
received. 
3.2.2 Sample Nomenclature 
The amino acid ester polyphosphazenes were named systematically as follows PP-A100, 
where the PP indicates that the backbone is a polyphosphazene and the A100 represents 
100 mole percent (mol %) substitution with L-alanine ethyl ester substituents. In all cases 
the amino acid is connected to the phosphorus atoms of the polyphosphazene backbone 
through the N terminus amino group. Note that the one-letter abbreviations for alanine, 
phenylalanine, methionine, and glutamic acid are A, F, M, and E, respectively, although 
through out this work A, F, and M, represent the ethyl esters of the L-amino acids and E* 
represents the ethyl ester of L-glutamic acid which has its side chain carboxylic acid 
protected with a benzyl group. 
3.2.3 Methods 
Described in the next three sections are three different substitution methods performed at 
different temperatures and with or without the initial reaction to liberate the free base of 
the amino acid prior to substitution. These were variations performed to determine their 
influence, if any, on the poly[(amino acid ester)phosphazene] products. 
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3.2.3.1 Low Temperature Two-Step Reaction (LT 2S) 
H-Ala-OEtHCl (1.70g, 11.1mmol, 2.6 equiv) was added to 10mL of THF and mixed 
with an excess (x.s.) of NEt3 (2.0mL, 1.5g, 14mmol, 3.3 equiv) for 1 hour at room 
temperature in a rubber septum sealed round bottom flask (Scheme 3.2, Mixture A).  In 
a separate flask, PDCP (0.50g, 4.3mmol of NPCl2 units, 1.0 equiv) recovered from the 
thermal ring opening polymerization step was dissolved in 5mL of THF.  Mixture A was 
cooled in an ice bath to 0°C and the PDCP solution was added drop-wise through the 
rubber septum over a time span of 1 hour (Mixture B).  Mixture B was then allowed to 
stir at room temperature for 48 hours after which the solution was filtered and the product 
was collected by repricipitation in hexanes.  The product was purified by dissolving the 
polymer in anhydrous THF and reprecipitating in hexanes 3 times.  The collected product 
was dried under vacuum at room temperature overnight.  Percent yield was determined 
based on the approximate weight of PDCP.  This technique slightly underestimates the 
yield collected as the PDCP is incapable of being dried completely and therefore the 
initial mass of PDCP added also includes the mass of residual solvents (THF and 
hexanes) from its purification after the thermal ring opening polymerization.  Scheme 3.2 
below shows the overall synthetic scheme and the chemical structures of the starting 
materials and polyphosphazene product. 
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Scheme 3.2: Reaction scheme for the low-temperature macromolecular substitution 
of L-alanine ethyl ester with poly[(dichloro)phosphazene] (PDCP) forming 
poly[bis(ethyl alanato)phosphazene] (PP-A100). 
This method was also utilized in the synthesis of L-phenylalanine ethyl ester (PP-F100) 
and L-methionine ethyl ester (PP-M100) polyphosphazene materials (Figure 3.2), 
substituting H-Phe-OEtHCl and H-Met-OEtHCl for H-Ala-OEtHCl, respectively.  
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Figure 3.2: Chemical structures of the L-phenylalanine ethyl ester (PP-F100) and L-
methionine ethyl ester (PP-M100) based polyphosphazene materials. 
3.2.3.2 One-Pot Room Temperature Reaction (1P RT) 
In an effort to simplify the substitution process the amino acid ester hydrochloride salt, 
triethylamine and poly[(dichloro)phosphazene] were all added to the reaction flask at the 
same time and allowed to stir for 72 hours at room temperature. H-Ala-OEtHCl (1.70g, 
10.4mmol, 2.6 equiv) was initially added to 10mL of anhydrous THF and sealed with a 
rubber septum.  In a separate flask, poly[(dichloro)phosphazene] (0.50g, 4.3mmol of 
NPCl2 units, 1.0 equiv) collected from the thermal ring opening polymerization was 
dissolved in 10mL of THF.  Next, triethylamine (2.0mL, 1.5g, 14mmol, 3.3 equiv) and 
the PDCP solution were both added through the septum into the reaction flask containing 
the amino acid ester and THF solution.  This mixture was stirred at room temperature for 
72 hours (Scheme 3.3).  The polyphosphazene product was purified in the same manner 
as the LT 2S method discussed above. 
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Scheme 3.3: Reaction scheme for the one-pot room temperature synthesis of 
poly[bis(ethyl alanato)phosphazene] (PP-A100) from L-alanine ethyl ester 
hydrochloride (H-Ala-OEtHCl) and poly[(dichloro)phosphazene] (PDCP). 
As with the LT 2S method, L-phenylalanine ethyl ester and L-methionine ethyl ester 
based polyphosphazenes were also synthesized by replacing H-Ala-OEtHCl with H-
Phe-OEtHCl and H-Met-OEtHCl, respectively (Figure 3.2). 
3.2.3.3 Room Temperature Two-Step Reaction (RT 2S) 
The last reaction method similar to the widely used macromolecular substitution 
technique found in the literature, which involves refluxing the amino acid ester 
hydrochloride salt with triethylamine to liberate the free base of the amino acid ester prior 
to its addition to poly[(dichloro)phosphazene]. H-Ala-OEtHCl (1.70g, 10.4mmol, 2.6 
equiv) was added to a round bottom flask with 2mL of NEt3 (1.5g, 14mmol, 3.3 equiv) 
and 10mL of anhydrous THF (BP 66°C).  The mixture was refluxed for 24 hours and the 
product was filtered.  The filtrate containing the free base of the amino acid ester was 
collected and added to another round bottom flask containing 0.50g of PDCP (4.3mmol 
of NPCl2 units, 1.0 equiv) dissolved in 10mL of THF.  This mixture was allowed to stir 
for 48 hours at room temperature (Scheme 3.4).  The resulting polyphosphazene material 
was collected and purified using the same techniques used in the LT 2S and 1P RT 
methods.      
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Scheme 3.4: Reaction scheme for the room temperature two-step substitution of 
poly[(dichloro)phosphazene] (PDCP) with L-alanine ethyl ester (H-Ala-OEtHCl). 
The L-phenylalanine ethyl ester (PP-F100) and L-methionine ethyl ester (PP-M100) 
polyphosphazene equivalents were made using the same reaction scheme and substituting 
H-Ala-OEtHCl for H-Phe-OEtHCl and H-Met-OEtHCl, respectively (Figure 3.2). 
3.3 Preparation of Glutamic Acid Ethyl Ester (E*) 
3.3.1 Materials 
Glass distilled dichloromethane (DCM), ethyl acetate (EtOAc), trifluoroacetic acid 
(TFA), sodium bicarbonate (NaHCO3), and anhydrous magnesium sulphate (MgSO4) 
were all obtained from Caledon Labs. Anhydrous ethanol (EtOH) was acquired from 
Commercial Alcohols Inc. (Brampton, ON). The DCM and EtOH were dried overnight 
over molecular sieves, 4Å and 3Å (Caledon Labs), respectively, prior to their use. 4-
Dimethylaminopyridine (DMAP) and 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide 
hydrochloride (EDCI) were purchased from Alfa Aesar. Protected functional amino 
acids, N-α-fluorenylmethyloxycarbonyl-L-glutamic acid γ-benzyl ester (Fmoc-
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Glu(OBzl)-OH) and N-α-tert-butyloxycarbonyl-L-glutamic acid γ-benzyl ester (Boc-
Glu(OBzl)-OH), were procured from EMD Millipore Corporation (Chicago, IL). All 
chemicals and solvents were used as received unless stated otherwise.  
3.3.2 Methods 
Before reacting the functional glutamic acid ethyl ester with 
poly[(dichloro)phosphazene], the glutamic acid must first be converted to an ester at the 
carboxyl terminus (COOH) and the amino terminus (NH2) must be deprotected to obtain 
the free base.  See Figure 3.3 for the chemical structures of the Fmoc and Boc protected 
glutamic acid starting materials noting that the esterification reaction will modify the 
COOH group to an ethyl ester. 
                       
N
H
OO
OH
O
O
O
Fmoc protecting group
Benzyl (Bzl) protecting group
Glutamic acid (Glu, E)
N
H
OO
OH
O
O
O
Boc protecting group  
Figure 3.3: Chemical structures of Fmoc- and Boc-protected glutamic acid that will 
be esterified to their ethyl ester amino acid derivatives.   
3.3.2.1 Ethyl Esterification of Fmoc-Glu(OBzl)-OH and Boc-Glu(OBzl)-OH 
The Fmoc-Glu(OBzl)-OH (1.0g, 2.2mmol, 1.0 equiv) amino acid, EDCI coupling agent 
(0.46g, 2.4mmol, 1.1 equiv), and DMAP (0.024g, 0.2mmol, 0.1 equiv) catalyst were 
added to a 25mL round bottom flask, evacuated, and placed under inert N2 atmosphere 
using a standard Schlenk line.  Next, 8mL of dry DCM and 0.15mL of anhydrous EtOH 
(0.12g, 2.5mmol, 1.1 equiv) were added to the reaction flask and the mixture was allowed 
to stir at 0°C in an ice bath for 3 hours, followed by stirring for another 3 hours at room 
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temperature (Scheme 3.5). The mixture was concentrated in vacuo using a rotary 
evaporator followed by drying overnight on the in-house vacuum line.  The crude product 
was weighed and taken up in 20mL of a 50/50 mixture of EtOAc and DI H2O for 
purification.  The solvent mixture containing the product was washed three times with 
15mL of a saturated solution of NaHCO3 in DI H2O and three times with 15mL of pure 
DI H2O at 60°C to remove water-soluble impurities.  The EtOAc layer was collected and 
dried over MgSO4 and concentrated in vacuo.  The same procedure was used to prepare 
Boc-Glu(OBzl)-OEt by replacing Fmoc-Glu(OBzl)-OH with Boc-Glu(OBzl)-OH. 
                 
Scheme 3.5: Expected reaction schemes for the ethyl esterification of Fmoc-
Glu(OBzl)-OH and Boc-Glu(OBzl)-OH to Fmoc-Glu(OBzl)-OEt and Boc-
Glu(OBzl)-OEt, respectively, using carbodiimide coupling chemistry. 
3.3.2.2 TFA Deprotection of Boc-Glu(OBzl)-OEt  
The Boc protecting group was deprotected by dissolving the Boc-Glu(OBzl)-OEt in 1:3 
TFA in DCM (Scheme 3.6).  The amount of TFA/DCM solution used was based on the 
mass of Boc-Glu(OBzl)-OEt to be deprotected with 2mL of 25% TFA in DCM for every 
75mg of protected amino acid. The TFA/DCM mixture and the amino acid were allowed 
to stir for 2 hours at room temperature and excess TFA was removed by bubbling N2 gas 
through the solution for a minimum of 3 hours.  Any remaining DCM solvent was 
removed in vacuo and the corresponding TFA salt of the deprotected glutamic acid ethyl 
ester was collected as a viscous oil.     
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Scheme 3.6: Boc deprotection of glutamic acid ethyl ester (Boc-Glu(OBzl)-OEt) 
using a 1:3 mixture of trifluoroacetic acid (TFA) in dichloromethane (DCM). 
3.4 Macromolecular Co-substitution of Non-Functional Amino Acids 
with Functional Glutamic Acid  
3.4.1 Materials 
Anhydrous tetrahydrofuran (THF) and glass-distilled hexanes-190 were obtained from 
Caledon Labs. Triethylamine (NEt3) was purchased from Sigma Aldrich. All non-
functional amino acid esters, L-alanine ethyl ester hydrochloride (H-Ala-OEtHCl), L-
phenylalanine ethyl ester hydrochloride (H-Phe-OEtHCl), and L-methionine ethyl ester 
hydrochloride (H-Met-OEtHCl), were from Alfa Aesar. The amine-deprotected glutamic 
acid ethyl ester (TFA- NH3+-Glu(OBzl)-OEt) was acquired from the preceding ethyl 
esterification and deprotection of Boc-Glu(OBzl)-OH procedures.   
3.4.2 Methods 
The general procedure for the synthesis of the co-substituted polyphosphazenes with both 
non-functional and functional amino acid esters was adapted from the one-pot room 
temperature substitution method used for the non-functional amino acids.  Rather than 
adding the amino acids sequentially, which has been shown to cause very specific 
substitution patterns depending on the type of nucleophile, half of the total amount of the 
non-functional amino acid ester to be reacted was mixed initially with PDCP.  After 
sufficient reaction time all of the functional amino acid ester was added to the mixture 
and allowed to react for 24 hours.  Finally, the remaining amount of non-functional 
amino acid ester was added and the complete mixture was allowed to react for an 
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additional 48 hours, at which point the reaction solution was filtered and the co-
substituted poly[(amino acid ester)phosphazene] was precipitated from the filtrate with 
hexanes. Described here in detail is the synthetic scheme for a co-substituted 
polyphosphazene with 90% Ala-OEt and 10% Glu(OBzl)-OEt (PP-A90E*10) substituents 
although similar materials containing 90% Phe-OEt/10% Glu(OBzl)-OEt (PP-F90E*10) 
and 90%Met-OEt/10%Glu(OBzl)-OEt (PP-M90E*10) were also synthesized (Figure 3.4). 
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Figure 3.4: Chemical structures of the co-substituted poly[(amino acid 
ester)phosphazene]s based on the non-functional amino acid esters, Ala-OEt, Phe-
OEt, Met-OEt, and side chain protected functional amino acid ester, Glu(OBzl)-
OEt.   
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H-Ala-OEtHCl (0.79g, 5.1mmol, 1.2 equiv) and 5mL of anhydrous THF were added to 
a 50mL round bottom flask and mixed at room temperature.  Next, 0.9mL of NEt3 (0.65g, 
6.4mmol, 1.5 equiv) and a 5mL solution of poly[(dichloro)phosphazene] (0.50g, 4.3mmol 
of NPCl2 units, 1.0 equiv) were added to the flask, the flask was sealed and the entire 
mixture was allowed to stir for 24 hours at room temperature.  After 24 hours, TFA- 
NH3+-Glu(OBzl)-OEt (0.32g, 0.86mmol, 0.2 equiv) dissolved in 5mL of THF and 0.2mL 
of NEt3 (0.15g, 1.5mmol, 0.3 equiv) and the flask was resealed and allowed to stir for yet 
another 24 hours at room temperature.  Finally, H-Ala-OEtHCl (0.79g, 5.1mmol, 1.2 
equiv), 5mL of anhydrous THF, and 0.9mL of NEt3 (0.65g, 6.4mmol, 1.5 equiv) were 
added to the reaction flask and the complete mixture was stirred at room temperature for 
an additional 48 hours (Scheme 3.7). Upon completion of the reaction, the mixture was 
filtered to remove insoluble impurities and the product was precipitated from the THF 
solution using hexanes.  Following this, the product was dissolved and precipitated from 
THF to hexanes a total of three times to help purify the polymer.  Lastly, the polymer was 
dried in vacuo overnight on the in-house vacuum line. 
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Scheme 3.7: One-pot three-stage room temperature reaction of a co-substituted 
poly[(amino acid ester)phosphazene] (PP-A90E*10 shown here) from the functional 
amino acid ester (TFA- NH3+-Glu(OBzl)-OEt), non-functional amino acid ester (H-
Ala-OEtHCl) and poly[(dichloro)phosphazene] precursor (PDCP). 
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3.5 Conjugation of a Model Compound to the Functional 
Polyphosphazenes 
In order to impart biological properties, materials are often coated or conjugated with 
biomolecules.  These biomolecules, such as growth factors and signaling components, are 
typically small proteins and including a functional moiety in the biomaterial that can 
allow for the attachment of these types of molecules.  Here, the pendant side chain 
carboxylic acid group of glutamic acid can be used as a site for biomolecule attachment 
and therefore its deprotection and reaction with a model compound have been explored as 
a proof of concept for attachment of biomolecules in the future.   
3.5.1 Materials 
The co-substituted functional polyphosphazenes containing glutamic acid side chains 
paired with non-functional amino acid side chains (PP-A90E*10, PP-F90E*10, and PP-
M90E*10) were obtained from the one-pot room temperature substitution method described 
above.  Anhydrous EtOH was purchased from Commercial Alcohols Inc.  The palladium 
on carbon (Pd/C) catalyst was purchased from Sigma Aldrich and had a loading of 10 wt. 
% on a matrix activated carbon support.  
3.5.2 Methods 
3.5.2.1 Hydrogenation of Benzyl Protecting Group 
Hydrogenation of the benzyl ester protecting groups on the glutamic acid side chains was 
performed under a hydrogen atmosphere using a Pd/C catalyst.  The PP-A90E*10 (84mg, 
0.27mmol of Ala/Glu(OBzl) substituted P=N units, 1.0 equiv) was dissolved in 4.5 mL of 
EtOH and the flask was evacuated under reduced pressure.  The Pd/C catalyst (6 mg, 7 
wt. % of polymer, 5.6μmol of Pd) was added to the reaction flask and the vessel was 
purged with H2.  The reaction mixture was allowed to stir for 3.5 hours at room 
temperature, at which point the hydrogenation was complete as determined by 1H NMR 
spectroscopy (Scheme 3.8), although the reaction also lead to disruption of the 
polyphosphazene backbone (see Chapter 4 – Results and Discussion for further 
information). The Pd/C catalyst was removed by filtration through celite and the solvent 
was removed in vacuo.   
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Scheme 3.8: Reaction scheme for the hydrogenation of benzyl ester protecting 
groups on glutamic acid in the co-substituted polyphosphazene of L-alanine ethyl 
ester (H-Ala-OEt) and benzyl protected L-glutamic acid ethyl ester (H-Glu(OBzl)-
OEt). 
3.6 Material Characterization 
3.6.1 Nuclear Magnetic Resonance Spectroscopy (NMR) 
Nuclear Magnetic Resonance (NMR) spectroscopy was performed on a Varian INOVA 
400 MHz spectrometer (1H 400.1 MHz, and 31P{1H} 161.8 MHz, Varian Canada Inc., 
Mississauga, ON). Chemical shifts are reported in parts per million (ppm) and were 
referenced relative to residual solvent signals of chloroform (CDCl3, δ 7.27 ppm) for all 
non-functional amino acid ester hydrochloride salts (H-Ala-OEtHCl and H-Met-
OEtHCl), Fmoc- and Boc-Glu(OBzl)-OH including products relating to the their 
esterification and deprotection, and all poly[(amino acid ester)phosphazene]s, except 
phenylalanine-based materials which were referenced to dimethyl sulfoxide (DMSO-d6, δ 
2.50 ppm). The hexachlorocyclotriphosphazene trimer and poly[(dichloro)phosphazene] 
TROP product were insoluble in CDCl3 and were therefore run in non-deuterated 
anhydrous THF with referencing to an external phosphoric acid standard (85% H3PO4, δ 
0.0 ppm). 
3.6.2 Fourier-Transform Infrared Spectroscopy (FTIR) 
Infrared spectroscopy was performed on a Bruker Vector 22 Spectrometer from Bruker 
Optics (Bruker Corporation, Billerica, MA) equipped with a MIRacle Attenuated Total 
Reflectance (ATR) diamond crystal plate sample cell (PIKE Technologies, Madison, 
WI).  The samples were run as solid films in air for 32 scans with a resolution of 4 cm-1 
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over the scan range of 600 cm-1 to 3200 cm-1.  Spectra were collected and processed in 
Opus 6.5 FTIR software (Bruker Optics) and reported in wavenumbers (cm-1).  
3.6.3 Thermogravimetric Analysis (TGA) 
Thermal decomposition of the polymers was determined using TGA on a SDT Q600 TA 
Instrument (TA Instruments – Waters LLC, New Castle, DE). A sample of 5 – 15 mg was 
placed in an aluminum cup and heated at a rate of 20°C/min from room temperature to 
500°C under dry nitrogen atmosphere. 
3.6.4 Differential Scanning Calorimetry (DSC) 
Glass transition temperatures (Tgs) and melting temperatures (Tms), if applicable, were 
determined using a DSC Q20 TA Instrument. A sample of approximately 5 –15 mg was 
placed in an aluminum pan and subjected to a heat/cool/heat temperature profile ranging 
from -100 to 100°C. The experiments were performed under dry nitrogen atmosphere at a 
heating rate of 10°C/min and all Tgs were collected from the second heating cycle.  
3.6.5 Gel Permeation Chromatography (GPC) 
Molecular weights and polydispersities were obtained from Gel Permeation 
Chromatography (GPC) experiments generously performed by PolyAnalytik Inc. 
(London, ON).  The experiments were conducted on a Viscotek TDA 302 GPC/SEC 
Instrument (Malvern Instruments, Malvern, UK) equipped with a triple detection system 
(Refractive Index (RI), Right Angle and Low Angle Light Scattering (RALS/LALS), and 
Four Capillary Differential Viscometer).  There were four styrene-divinylbenzene 
SupeRes™ size exclusion columns (PolyAnalytik Inc., London, ON) connected in series, 
PAS-105, PAS-104, PAS-103, and PAS-102.5, with exclusion limits of 4 × 106, 4 × 105, 
7 × 104, and 2 × 104 Daltons (Da), respectively.  Samples (10mg/mL) dissolved in the 
eluent, consisting of 10 mM tetra-n-butylammonium nitrate in THF at 30°C, were passed 
through a 0.22 μm Teflon filter prior to injection (100 μL) into the instrument at a flow 
rate of 0.7 mL/min.  The absolute molecular weights (number average (Mn) and weight 
average (Mw)) and polydispersities (PDI, Mw/Mn) were obtained using the triple detection 
method and are presented in Daltons (Da, g/mol).  Molecular weights of the 
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polyphosphazenes were also calculated relative to polystyrene standards with known 
molecular weights using refractive index detection.   
3.7 Cytotoxicity Studies of Polymeric Films Using MTT Assays 
3.7.1 Thin Film Preparation 
Thin films were prepared by adding 30.5 μL of a 1% weight by volume (w/v) solution of 
the polymer in absolute ethanol to the bottom of the well of a 96-well tissue culture plate 
(BD Falcon™, Franklin Lakes, NJ).  The films were allowed to dry at room temperature 
for 24 hours.  Uncoated tissue culture polystyrene (TCPS) were used as positive controls 
in these experiments. The tissue culture plate, including the dried films, was disinfected 
with ultraviolet (UV) light overnight.  For pre-conditioning, the films were treated with 
Hank’s Balanced Salt Solution (HBSS, 200 μL, Invitrogen Canada Inc., Burlington, ON) 
at room temperature overnight. 
3.7.2 Fibroblast (NIH-3T3) Cell Study 
Cell toxicity and proliferation assays were assessed using mouse embryonic fibroblasts 
(NIH-3T3 cell-line), which were seeded in the 96-well plate at a seeding density of 8,000 
cells/well with 200 μL/well of advanced DMEM (GIBCO® Invitrogen, Burlington, ON, 
Canada) containing 5% FBS, 1% antibiotics, and 0.2 mM L-glutamine. The cells were 
maintained in a humidified incubator at 37°C and 5% CO2.  At time points of 1, 3, and 5 
days cells were analyzed for viability using the MTT assay protocol described below.   
3.7.3  MTT Assay Protocol 
Cell toxicity and proliferation were quantified by colorimetric assays of the metabolic 
activity of viable cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) (Vybrant® MTT Cell Proliferation Assay Kit, Invitrogen Canada Inc.) 
The MTT tetrazolium dye is reduced to insoluble formazan salts in correspondence to the 
activity level of NADPH-dependent oxidoreductase enzymes of metabolically active cells 
producing a purple colour.  The concentration of the formazan salts, and therefore 
metabolic activity level of the cells present, is determined using optical density at λ = 570 
nm. At time points of 1, 3, and 5 days, the spent culture media was aspirated and replaced 
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with fresh media (100 μL) followed by MTT (10 μL, Component A) and allowed to 
incubate for 4 hours. Sodium dodecyl sulphate (SDS) in dilute acid (100 μL, Component 
B) was added to the wells to solubilize the water insoluble formazan salts upon thorough 
mixing and incubation for another 4 hours.  The resultant coloured solution was 
quantified using a BioTek EL307C multiplate reader (BioTek Instruments, Inc., 
Winooski, VT) at the maximum absorbance wavelength of the formazan solution (570 
nm).  The results of the MTT assays presented as the mean ± standard deviation for 
experiments conducted with 5 replicates (n=5). Statistical analysis was determined from 
two-way ANOVA with Bonferroni post-tests using GraphPad Prism 4 (GraphPad 
Software, Inc., La Jolla, CA), where a p<0.05 was deemed statistically significant.       
3.8 Cell Morphology and Adhesion Studies on Polymer Films Using 
Confocal Microscopy      
3.8.1 Thin Film Preparation 
Polymer film-coated coverslips were prepared by twice dip-coating glass coverslips (12 
mm diameter) in 1% w/v solutions of the polymers in absolute EtOH. After each coat the 
films were allowed to dry overnight at room temperature in vacuo. Once both coats had 
been thoroughly dried in vacuo, one glass coverslip was placed in each well of a 24-well 
tissue culture plate. Uncoated glass coverslips were used as a positive control in these 
experiments.  The cells were seeded at a density of 30,000 cells/well and cultured for 3 
days prior to fixation and staining. 
3.8.2 Cell Fixation, Staining, and Imaging 
For immunostaining studies, cells were washed with PBS pre-warmed to 37°C 
immediately prior to fixing at ambient temperature for 10 min in 4% paraformaldehyde 
solution (1 mL; EMD Chemicals, Gibbstown, NJ) in divalent cation-free PBS. Following 
3 washes in PBS, permeabilized with 0.1% Triton X-100 (0.5 mL; VWR International, 
Mississauga, ON) in PBS for 5 min and again washed 3 times with PBS. Following 3 
washes in PBS, the cells were incubated in the dark at ambient temperature with Alexa 
Fluor® 568-conjugated phalloidin (1:50 dilution; Invitrogen Canada Inc., Burlington, 
ON) for 20 min in a 1% BSA/PBS solution to label the F-actin of the cytoskeleton 
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followed by another 3 washes with PBS. The fibroblasts were then counterstained with 
4’-6-diamidino-2-phenylindole dihydrochloride (DAPI, 300 nM in PBS, 0.5 mL; 
Invitrogen Canada Inc., Burlington, ON) for 5 min to label the nuclei and again washed 3 
times with PBS. Coverslips were mounted on microscope slides with SHURMountTM – 
Toluene Based Liquid Mounting Media (Triangle Biomedical Sciences, Inc., Durham, 
NC). Samples were analyzed with a Zeiss LSM 5 Duo confocal microscope with 9 laser 
lines and appropriate filters (Carl Zeiss Canada Ltd., Toronto, ON). 
3.9 Electrospinning of Polyphosphazenes and Polyphosphazene/ 
Polycaprolactone Blends 
3.9.1 Electrospinning Parameters 
Two approaches were investigated to develop 3-D fibers of the polyphosphazene 
materials.  Solutions of poly[bis(ethyl alanato)phosphazene] (PNEA) alone and a mixture 
of PNEA and polycaprolactone (PCL, Mn = 80kDa, Sigma-Aldrich, Oakville, ON, 
Canada) in various solvents and co-solvent mixtures using chloroform (CHCl3), N,N-
dimethylformamide (DMF), ethanol (EtOH), tetrahydrofuran (THF), and 
dichloromethane (DCM) were attempted to be electrospun. The polymer solutions ranged 
in concentration from 3 to 37 % w/v and all solvents were from Caledon Labs except 
ethanol, which was from Commercial Alcohols Inc. The viscous polymer solutions were 
loaded into 0.5 mL glass syringes (Becton, Dickinson and Co., 0.5 cc, New Jersey, USA) 
equipped with blunt-tip stainless steel needles between 18- and 22-gauge (inner diameter 
0.838 – 0.413 mm).  An alligator clip was attached to the middle of the needle connecting 
it to the high voltage DC power supply (ES30P, Gamma High Voltage, USA) with an 
applied voltage between 7 and 20 kV and a syringe pump (KD101, KD Scientific, USA) 
was used to push the solution through the horizontal syringe and needle at a constant flow 
rate of 0.1 mL/h.  An aluminium foil-covered static collector placed at a distance of 7 to 9 
cm from the needle tip was used to catch the polymer fibers during the electrospinning 
process.    
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3.9.2 Scanning Electron Microscopy (SEM) Imaging of Electrospun Fibers  
The electrospun fibers were visualized using scanning electron microscopy (S- 3400N, 
Hitachi, Ltd., Tokyo, Japan). The mat was mounted on carbon-taped aluminum stubs and 
coated with 5 nm of osmium using a sputter coating technique (Filgen OPC80T Osmium 
Plasma Coater, Filgen Nanosciences & Biosciences Inc., Japan). Secondary electron 
detection was achieved at a working distance of 10 mm and accelerating voltages 
between 3 and 5 kV at various magnifications. Images were acquired and processed using 
ImageJ software (NIH, Bethesda, MD).  
 
 
 
 
55 
 
Chapter 4  
4 Results and Discussion 
4.1 Optimization of Thermal Ring Opening Polymerization 
Considering the limitations of the traditional thermal ring opening polymerization 
discussed in Chapter 1 and that it requires large amounts of starting material, a facile 
polymerization technique was developed in this work.  The new method overcame the 
restrictions of large-scale synthesis making the procedure more ideal for the development 
of novel polyphosphazene biomaterials.  The new method also bypassed the requirement 
of trimer purification prior to polymerization and handling of all materials in inert 
atmosphere using expensive glovebox techniques. The success of the new synthesis 
process was achieved by monitoring the reaction progress of 1g polymerizations using 
31P NMR and comparing the relative peak heights and integrations of the starting material 
and product.  The polymerizations were performed at 230°C for time periods of 20 to 26 
hours. From the literature, it has been well documented that 
hexachlorocyclotriphosphazene (cyclic trimer) gives rise to a single peak at a chemical 
shift of approximately +20 ppm, where as poly[(dichloro)phosphazene] (linear high 
polymer) appears as a singlet at approximately -17 ppm.67  As can be seen from Figure 
4.1 the expected shifts in 31P NMR spectroscopic analysis of both the trimer starting 
material and PDCP linear precursor coincided with those previously presented in the 
literature. 
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Figure 4.1: 31P NMR of the time-varied facile polymerization of 
hexachlorocyclotriphosphazene (1) to purified poly[(dichloro)phosphazene] (5) at 
230°C. Spectra (2), (3), and (4) are for 21, 23, and 25 hour polymerizations, 
respectively, without purification. 
Polymerizations for longer than 25 hours led to cross-linked materials that were insoluble 
and could not be reacted further to produce poly[(amino acid ester)phosphazene]s.  From 
comparison of relative peak heights and integration values in the time-varied 
polymerizations shown in Figure 4.1 and Table 4.1, respectively, the best conversion of 
hexachlorocyclotriphosphazene to poly[(dichloro)phosphazene] without cross-linking 
was achieved at 25 hours reaction time at 230°C. These reaction conditions were used for 
all subsequent polymerizations. 
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Table 4.1: Summary of the time-varied polymerizations of 
hexachlorocyclotriphosphazene (trimer) to poly[(dichloro)phosphazene] (linear 
precursor) with their respective yields and extent of conversion.  
 
4.2 Comparison of the Three Macromolecular Substitution Methods 
Using Non-Functional Amino Acid Esters 
There are two reported methods of amino acid substitution onto 
poly[(dichloro)phosphazene] that have been successfully used to make poly[(amino acid 
ester)phosphazene]s.77, 78, 83, 84, 95  Both methods involve forming the free base of the 
amino acid ester by reacting the hydrochloride salt of the amino acid ester with 
triethylamine under refluxing conditions for 3 hours to 24 hours. The first and most 
common method, referred to as the RT 2S reaction in the methods section, performs the 
actual substitution reaction at room temperature, whereas the other method, referred to as 
the LT 2S  reaction, performs the substitution at 0°C in an ice bath.  In an effort to 
overcome the need to liberate the free base and simplify the overall reaction, a method 
that involves adding the hydrochloride salt of the amino acid ester, triethylamine and the 
poly[(dichloro)phosphazene] linear precursor all together at one time, named the 1P RT 
reaction, was investigated. This method was proposed since TEA, the base used to form 
the free base from the hydrochloride salt, is non-nucleophilic and should theoretically not 
react in a substitution with the poly[(dichloro)phosphazene] linear precursor.  An 
adaptation to the low temperature method described in the literature was also compared, 
where refluxing the hydrochloride salt of the amino acid ester with TEA was instead 
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performed at room temperature rather than at reflux, followed by substitution onto 
poly[(dichloro)phosphazene] at 0°C. The one-pot method was proven successful and the 
resulting polymers based on non-functional amino acid ethyl esters were characterized 
and analyzed in comparison to both of the previously described methods found in the 
literature.  The amino acid esters used for this comparison included, alanine ethyl ester 
(H-Ala-OEt), phenylalanine ethyl ester (H-Phe-OEt), and methionine ethyl ester (H-Met-
OEt), since these materials have all been previously reported in the literature with 
associated characterization and thermal data.64, 83, 84, 94, 95, 97, 105, 114-118  Also, ethyl esters of 
amino acids were chosen since ethanol is one of the anticipated degradation products and 
can be easily processed by cells.  The amino acids were chosen on the basis of having 
side chains that are a short alkyl chain (alanine), a rigid and bulky aromatic chain 
(phenylalanine), a long and flexible chain (methionine) and a side chain that contains a 
heteroatom (methionine).  Incorporating amino acids with very different side chains gives 
tunability to the polymers and allows for adjustment of both the degradation and 
mechanical properties of the materials to suit the intended biomedical application.83   
4.2.1 FTIR, 1H NMR, and 31P NMR Characterization  
Structural characterization techniques used to compare the three methods were nuclear 
magnetic resonance (NMR) spectroscopy and Fourier Transform Infrared (FTIR) 
spectroscopy, which are summarized in Table 4.2. 
Table 4.2: Summary table of the yields, 1H NMR, 31P NMR, and FTIR analyses of 
PP-A100, PP-F100, and PP-M100 synthesized by the three methods (LT 2S = low 
temperature two-step reaction, 1P RT = one-pot room temperature reaction, and 
RT 2S = room temperature two-step reaction). Note: As described in the methods 
section, the mass of poly[(dichloro)phosphazene] (PDCP) is approximate since it 
cannot be dried fully and therefore the percentage yields shown are underestimated 
since yield calculations are based on PDCP  as the limiting reagent. 
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The FTIR spectroscopic analyses for the alanine, phenylalanine, and methionine ethyl 
ester polyphosphazenes synthesized using the three different methods are shown in 
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Figures 4.2 – 4.4.  Enlarged spectra of specific regions to show peak broadening have 
been included in the Appendix (Appendix 2 - 4).  
             
Figure 4.2: FTIR comparison of PP-A100’s prepared from three different synthetic 
methods. The spectra correspond to L-alanine ethyl ester hydrochloride salt (black), 
and PP-A100’s from LT 2S method (blue), 1P RT method (green), and RT 2S method 
(red). 
         
Figure 4.3: FTIR comparison of PP-F100’s prepared from three different synthetic 
methods. The spectra correspond to L-phenylalanine ethyl ester hydrochloride salt 
(black), and PP-F100’s from LT 2S method (blue), 1P RT method (green), and RT 2S 
method (red). 
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Figure 4.4: FTIR comparison of PP-M100’s s prepared from three different synthetic 
methods. The spectra correspond to L-methionine ethyl ester hydrochloride salt 
(black), and PP-M100’s from LT 2S method (blue), 1P RT method (green), and RT 
2S method (red). 
The 1H NMR spectroscopic analyses for the alanine, phenylalanine, and methionine ethyl 
ester polyphosphazenes synthesized using the three different methods are shown in 
Figures 4.5 – 4.7.  
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Figure 4.5: 1H NMR comparison of PP-A100’s prepared from three different 
synthetic methods. The spectra correspond to L-alanine ethyl ester hydrochloride 
salt (black), and PP-A100’s from LT 2S method (blue), 1P RT method (green), and 
RT 2S method (red). All small, unlabeled peaks are impurities that cannot be 
removed from dissolution/reprecipitation techniques.  
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Figure 4.6: 1H NMR comparison of PP-F100’s prepared from three different 
synthetic methods. The spectra correspond to L-phenylalanine ethyl ester 
hydrochloride salt (black), and PP-F100’s from LT 2S method (blue), 1P RT method 
(green), and RT 2S method (red). All small, unlabeled peaks are impurities that 
cannot be removed from dissolution/reprecipitation techniques. 
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Figure 4.7: 1H NMR comparison of PP-M100’s prepared from three different 
synthetic methods. The spectra correspond to L-methionine ethyl ester 
hydrochloride salt (black), and PP-M100’s from LT 2S method (blue), 1P RT method 
(green), and RT 2S method (red). All small, unlabeled peaks are impurities that 
cannot be removed from dissolution/reprecipitation techniques. 
Since the 31P NMR spectra consist of a broad single or bimodal peak for all of the 
poly[(amino acid ester)phosphazene]s, they have been included as tabulated data (Table 
4.2) rather than spectra for simplicity.  As an example of the changes in 31P NMR from 
hexachlorocyclotriphosphazene (trimer) to poly[(dichloro)phosphazene] (PDCP, linear 
precursor) to an amino acid ester substituted polyphosphazene, the transition from trimer 
to PP-M90E*10 has been included (Figure 4.8). 
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Figure 4.8: 31P NMR of the transition from hexachlorocyclotriphosphazene (cyclic 
trimer) to poly[(dichloro)phosphazene] (PDCP) and finally to the methionine ethyl 
ester and benzyl protected glutamic acid ethyl ester co-substituted polyphosphazene 
(PP-M90E*10). 
From the FTIR, 1H NMR, and 31P NMR data it is evident that all of the substitution 
methods with all of the non-functional amino acid esters were successful, with the 
exception of the low temperature two-step reaction with methionine ethyl ester giving 
mixed results.   
In the FTIR spectra of the PP-A100’s peaks corresponding to the C-H stretch (alkanes) and 
N-H stretch were observed between 3100 - 2700 cm-1, correlating to the side chain 
methyl group, α-carbon, and ethyl C-H bonds and the N-H bonds of the amine terminus 
of the amino acid, respectively.  The sharp peak at 1740 cm-1 corresponds to the C=O 
stretch of the ester carbonyl of the amino acid.  The P=N of the backbone P-NH bonds 
that connect the amino acid esters to the phosphorus atoms in the backbone are observed 
as a broadening of peaks between 1210 – 1145 cm-1 in comparison to the already present 
peaks from L-alanine ethyl ester itself.  A similar phenomenon is observed with the        
P-NH, where peaks between 850 – 775 cm-1 are broadened relative to alanine ethyl ester 
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alone. The incidence of these peak broadenings, which could realistically be two separate 
bands appearing as one, fall within the areas previously attributed to P=N and P-NH 
bonds in the literature.64, 103, 105, 114, 119-124 Peak-broadened spectra are included in the 
Appendix (Appendix 2) for reference, although these broadened peaks alone are not 
sufficient to definitively conclude that the PP-A100 has been formed.  As such, 1H and 31P 
NMR spectra were collected and analyzed to verify the success of the PP-A100 syntheses. 
From the 1H NMR spectra, it is apparent that the appropriate chemical shifts and splitting 
that correspond to the types of protons on L-alanine ethyl ester are present, with minimal 
impurities.  The 1H NMR spectra of the PP-A100 synthesized via the 1P RT method will 
be discussed in detail although the PP-A100’s from the other two methods gave similar 
spectra with only minor differences in chemical shifts (see Table 4.2).  The broad singlet 
at a chemical shift of 8.69 ppm with non-integer integration between 1 – 2 protons 
represents the protons bound to the amine terminus of the amino acid since it is 
somewhat similar to an amide (HRN-P=N vs. HRN-C=O). The amine peak has either not 
been observed or is omitted from the literature; thus it was of interest to see this peak in 
this work83, 84, 94, 97  Since amine protons do not always appear in 1H NMR spectra based 
on whether or not the NMR solvent can undergo hydrogen-deuterium exchange reactions, 
the polymer was also analyzed in deuterated methanol (MeOH-d4), a solvent that readily 
undergoes exchange, to confirm that this peak corresponded to an amine and not some 
other impurity.  Upon running 1H NMR of the PP-A100 in MeOH-d4 the peak at 8.69 ppm 
disappeared, further confirming the identity of the peak as that of the amine protons.  The 
non-integer integration for this peak leads us to believe that not all of the nitrogen atoms 
have been deprotonated (i.e. 2 protons to 1 proton) after the substitution reaction, leaving 
the polymer cationic at some or all of the nitrogen atoms, unlike what has been shown in 
the chemical structures reported in the literature that show the nitrogen atoms bearing 
only 1 proton and a neutral charge.  Next, the multiplet at 4.25 ppm (integration for 3H) 
corresponds to the proton on the α-carbon and the two protons of the CH2 of the ethyl 
ester.  This is slightly different than some literature sources83, 84, 94, 97, 116, which identify 
two separate peaks at 4.4 and 4.1 ppm corresponding to the proton on the α-carbon and 
ethyl group, respectively, rather than the multiplet for both that is found in this work.  
Lastly, the doublet at 1.72 ppm (integration for 3H) and triplet at 1.30 ppm (integration 
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for 3H) agree well with the literature with only minor differences in chemical shift. They 
correspond to the methyl side chain of the amino acid, which is split into a doublet by the 
proton on the α-carbon, and the CH3 group of the ethyl ester, which is split into a triplet 
by the two methylene protons of the ethyl group, respectively.   
In 31P NMR analysis of the PP-A100’s, broad humps with chemical shifts between 1.13 
and -1.42 ppm were observed, which is comparable to the literature as shifts between -
1.10 and -3.50 ppm have been reported and broadened peaks are to be expected with 
polyphosphazenes.67 Overall, despite these subtle differences, the PP-A100’s were 
successfully synthesized via all three reaction methods. 
 In the FTIR spectra of the PP-F100’s peaks corresponding to the C-H stretch (alkanes) 
and N-H stretch were observed between 3100 – 2700 cm-1. The sharp peak at 1740 cm-1 
corresponds to the C=O stretch of the ester carbonyl of the amino acid.  The P=N of the 
backbone and the P-NH bonds broadening of peaks between 1210 – 1145 cm-1 and 865 – 
855 cm-1, respectively, in comparison to the already present peaks from L-phenylalanine 
ethyl ester alone. Another peak, which was not observed with the PP-A100’s, but is 
observed in the PP-F100’s is the aromatic C-H out of plane vibration from the benzene 
ring in the amino acid side chain.  Peak broadening spectra are included in the Appendix 
(Appendix 3) for reference, although, like with the PP-A100’s, these broadened peaks 
alone are not conclusive enough. Therefore, 1H and 31P NMR spectra were also analyzed 
to confirm the success of the PP-F100 syntheses. 
In the 1H NMR spectra of the PP-F100’s the chemical shifts that correspond to the types of 
protons on L-phenylalanine ethyl ester are present, along with a few trace impurities. The 
1H NMR spectra of the PP-F100 synthesized via the 1P RT method will be discussed in 
detail although the PP-F100’s from the other two methods gave similar spectra with only 
slight differences in chemical shifts (see Table 4.2). The broad singlet at a chemical shift 
of 8.71 ppm with non-integer integration between 1 – 2 protons represents the protons 
bound to the amino terminus of the amino acid.  Like with the PP-A100’s, this integration 
indicates that some or all of the nitrogen atoms are likely to have 2 protons, implying a 
positive charge.  The multiplet at 7.30 ppm (integration for 5H) corresponds to the 
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aromatic protons of the benzene ring in the phenylalanine side chain, which is not far off 
of the 7.6 ppm peak reported in the literature84, 95 and still falls in the typical range for 
aromatic protons (8.5 – 6.0 ppm). The proton attached to the α-carbon of the amino acid 
was observed as a multiplet with a chemical shift of 4.24 ppm.  The quartet of doublets at 
4.09 ppm (integration for 2H) signifies the methylene of the ethyl group since the two 
protons are each split by the terminal CH3 of the ethyl group, yet they each have their 
own unique magnetic environments and appear at slightly different chemical shifts giving 
rise to the overlap of two quartets slightly offset from one another. Two doublets of 
doublets at 3.21 ppm (integration for 1H) and 3.06 ppm (integration for 1H), represent 
the two protons on the methylene group of the phenylalanine side chain.  Both of these 
protons see the α-carbon splitting them into a doublet and, like the protons described 
above, they also have their own unique environments and thus split each other leading to 
the doublet of doublet that is observed. Lastly, the triplet at 1.08 ppm (integration for 3H) 
corresponds to the CH3 of the ethyl group, which is split by the two methylene protons on 
the adjacent carbon.      
In 31P NMR analysis of the PP-F100’s, broad singlets or bimodal humps with chemical 
shifts between -0.97 and -9.12 ppm were observed although no data has been reported in 
the literature for mono-substituted PP-F100 polymers.  There was only one spectrum that 
gave rise to a bimodal hump, that being the PP-F100 made via the room temperature two-
step method, which may suggest that incomplete substitution occurred.  This is postulated 
since the chemical shift of PDCP where chlorine atoms are the only substitute gives rise 
to a chemical shift of -17.27 ppm and -9.12 ppm, which is somewhat in between the 
single peak PP-F100 chemical shifts observed at -1.55 and -0.97 ppm and that of PDCP.  
Therefore, it is proposed that the hump at -9.12 ppm corresponds to phosphorus atoms 
with 1 L-phenylalanine ethyl ester and 1 chlorine substituent, which could be due to the 
increased steric hindrance of the bulky phenylalanine groups in comparison to both 
alanine and chlorine substituents. Overall, despite these minor differences the PP-F100’s 
were successfully synthesized via all three reaction methods according to FTIR, 1H NMR 
and 31P NMR characterization, although substitution may be incomplete in the room 
temperature two-step reaction. 
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Peaks from the C-H stretch (alkanes), N-H stretch, and C=O stretch of the ester carbonyl 
gave rise to peaks at wavenumbers similar to those of PP-A100’s and PP-F100’s. Also, the 
P=N of the backbone and the P-NH bonds showed broadening of peaks between 1210 – 
1145 cm-1 and 855 – 840 cm-1, respectively, in comparison to the already present peaks 
from L-methionine ethyl ester alone. Peak broadening spectra are included in the 
Appendix (Appendix 4) for reference. 1H and 31P NMR spectra were also analyzed to 
prove the success of the PP-M100 syntheses.  
The chemical shifts in the 1H NMR spectra of the PP-M100’s relate to the types of protons 
present in L-methionine ethyl ester.  The 1H NMR spectra of the PP-M100 synthesized via 
the 1P RT method will be discussed in detail although the PP-M100’s from the other two 
methods gave similar spectra with only slight differences in chemical shifts (see Table 
4.2). The broad singlet peak at a chemical shift of 8.84 ppm represents the protons on the 
amino terminus of the amino acid ester and integrates for a non-integer value between 1 – 
2 protons indicating full or partial cationic charge at the nitrogen atom.  In the PP-M100 
synthesized via the low temperature two-step method this peak is not present, which 
could indicate that the nitrogen atoms were fully deprotonated after substitution and are 
more capable than their protonated cationic counterpart at interacting in a hydrogen-
deuterium exchange reaction with the solvent.  It could also indicate that the amine 
protons are some how lost and that the reaction did not proceed as expected, although the 
first scenario is probably more likely since 1H NMR spectra of poly[(amino acid 
ester)phosphazene]s lacking the amine protons are common in the literature.95, 118 The 
multiplet at 4.28 ppm (integration for 3H) corresponds to the proton on the α-carbon and 
the methylene protons of the ethyl group.  The methylene protons of the methionine side 
chain appear at 2.79 and 2.38 ppm as multiplets with integration for 2 protons each. The 
singlet at 2.13 ppm (integration for 3H) represents the methyl group next to the sulfur 
atom in the methionine side chain, which is isolated from other protons by distance and 
therefore is unsplit.  Finally, the triplet at 1.32 ppm (integration for 3H) symbolizes the 
methyl of the ethyl group, which is split into a triplet by the two protons of the adjacent 
methylene group.          
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In 31P NMR analysis of the PP-M100’s, broad humps with chemical shifts between 3.51 
and -0.43 ppm were observed which is comparable to the literature as a shift of -0.226 
ppm has been reported.118 Taken together, PP-M100’s were successfully synthesized via 
all three reaction methods except for slight differences in characterization spectra with 
the LT 2S method, although low yields and more demanding procedures have prevented 
further exploration of materials synthesized via the LT 2S method. 
Upon analysis of the PP-A100, PP-F100, and PP-M100 polymers synthesized via the three 
substitution methods using FTIR, 1H NMR, and 31P NMR spectroscopy, it was 
determined that there was very little difference between the LT 2S and 1P RT methods, in 
terms of successful substitution and purity, and further characterization and comparison 
would only be performed on polymers made from the well-established RT 2S and the 
new 1P RT methods. This decision was also influenced by the improved yields of the 
one-pot synthesis over the LT 2S procedure (see Table 4.2). 
4.2.2 TGA, DSC, and GPC Characterization 
TGA and DSC were used to analyze the thermal properties of the materials, including 
their decomposition temperature (Td), glass transition temperature (Tg), and melting 
temperature (Tm), if applicable. Tabulated data from both TGA and DSC analyses has 
been included in Table 4.3. The TGA analyses of the 1P RT and RT 2S synthesized 
materials are included in Figure 4.9.    
Table 4.3: Summary of thermal data from TGA and DSC analysis for PP-A100, PP-
F100, and PP-M100 materials synthesized via either the 1P RT or RT 2S method. The 
decomposition temperatures are presented as the peak decomposition temperatures 
rather than onset, meaning they are the values of maximal rate of change in weight 
% for all phases of the decomposition (i.e. maxima of the derivative of weight % 
plot). 
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Figure 4.9: TGA analysis for the PP-A100, PP-F100, and PP-M100 materials prepared 
using the 1P RT and RT 2S methods. The top graph represents the weight percent 
vs. temperature, where as the bottom graph shows the derivative of weight percent 
vs. temperature. 
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From the TGA analyses, it is clear that the phenylalanine-based polyphosphazenes (PP-
F100’s) were the most thermally stable materials as can be seen by their higher 
temperature of decomposition onset in comparison to the PP-A100 and PP-M100 materials.  
This is due to the increased rigidity of the bulky aromatic side chain with very stable C=C 
bonds.  The PP-A100 and PP-M100 materials on the other hand do not contain any C=C 
bonds in their side chains and thus decomposed at lower temperatures. The bimodal 
decomposition profile of the PP-F100’s (which is more obvious from the derivative of 
weight % plot) can be accounted by the initial decomposition of the amino acid backbone 
in the first peak and followed by the actual decomposition of the aromatic ring of the side 
chain in the second peak. For the PP-M100’s, which had the second highest onset 
decomposition temperature, there was also a two-phase decomposition that occurred, 
with the first peak likely corresponding to the decomposition of the amino acid backbone, 
like in the PP-F100’s, followed by decomposition of the methionine side chains.  It is 
likely that the PP-M100’s had the intermediate decomposition temperature due to their 
long aliphatic chains in comparison to the short methyl and bulky aromatic side chains of 
alanine and phenylalanine, respectively.  Lastly, the PP-A100 materials had the lowest 
decomposition onset temperature due to their small aliphatic side chain containing only 
C-C and C-H bonds.  The decomposition of these materials were primarily single stage 
with a slight hump on the edge of the curves indicating that both the backbone and the 
side chain of the amino acids degraded at approximately the same temperature.  Overall, 
decomposition onset temperatures for all of the materials were in excess of 140°C 
although the individual peak Td values have been included in Table 4.3. The 
decomposition temperatures of poly[(amino acid ester)phosphazene]s are not well 
recorded in the literature besides one paper that cites the Tds of PNEA and PNEF as 136 
and 185°C, respectively.84  The reason that the decomposition profiles do not completely 
reach a weight % of zero is that the inorganic backbone components (P=N and P-N 
bonds) decomposes at temperatures in excess of 500°C and these temperatures are not 
reached in these experiments.       
The DSC thermograms of the one-pot room temperature and room temperature two-step 
synthesized materials are included in Figure 4.10.   
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Figure 4.10: DSC thermograms of PP-A100, PP-F100, and PP-M100 materials 
prepared using the 1P RT and RT 2S methods. The glass transition temperatures 
(Tgs), which were collected from the second heating cycle, range from -41.8 to 
+46.3°C. 
 From the DSC, it is evident that the polymers based on the three different amino acids 
give rise to materials with substantially different Tg values, which is important with 
respect to scaffold fabrication. Ideal scaffold materials should have Tgs near body 
temperature (37°C) so that they exhibit properties of both the rubbery and glassy 
material, which better mimics the natural ECM.  The rubbery characteristics are ideal for 
cell-material interactions that enhance cell proliferation on the materials, whereas the 
hard and brittle characteristics impart mechanical strength to the scaffold as it acts as a 
support material for neo-tissue growth.125-128  The bulky and rigid aromatic ring in the 
side chain of phenylalanine increases the Tgs of PP-F100’s (42.8 to 46.3°C) in comparison 
to both PP-A100’s and PP-M100’s, which is in agreement with the literature where alanine, 
phenylalanine, and methionine based polyphosphazenes have Tgs in the order of PNEA ≈ 
PNEM < PNEF.83, 84, 94, 95, 97, 115, 116, 118 The steric hindrance of the bulky aromatic side 
chains of phenylalanine decreases movement in the polymer backbone thus increasing 
their Tgs. This trend is maintained as the PP-M100’s (-23.3 to -19.4°C) have Tgs that are 
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similar to the PP-A100’s and lower than PP-F100’s. The increased flexibility of the 
aliphatic side chain in methionine in comparison to the rigid ring structure in 
phenylalanine lowers the Tgs of the PP-M100 materials. The substantial difference in Tg 
values for the PP-A100’s prepared using the two different methods may be due to large 
differences in molecular weights, which is known to have an effect on glass transitions in 
low molecular weight materials.129 Another possibility is that residual solvent could have 
had a plasticizing effect on the RT 2S synthesized material, thus giving the appearance of 
a decreased Tg value.  Overall, the Tgs for the PP-A100’s synthesized in this work fall 
outside of the range of Tgs presented in the literature (-10 to 19°C),83, 84, 94, 97, 116 but again 
this could potentially be accounted for by significant differences in the molecular weights 
of the materials, as they are prepared using different methods.  When comparing the 
literature cited PNEFs (40 to 68°C)84, 95 to the Tgs of the PP-F100’s prepared in this work 
they are very similar with Tgs ranging from 42.8 to 46.3°C, which is promising.  To the 
best of our knowledge only one Tg for PNEM has been reported in the literature (9°C),118 
so comparison of this work to that single study should be taken with caution, although the 
Tgs of the PP-M100’s synthesized in this work are far lower than the cited Tg, they are on 
par with the PP-A100’s, which is in agreement with the literature.  
The molecular weights of the polymers synthesized were determined by means of GPC 
using triple-detection (light scattering, refractive index, and viscometry). Light scattering 
detection relies on monitoring the changes in refractive index of the polymer solutions 
with varying concentrations, also known as the differential index of refraction or the 
refractive index increment (dn/dc), to determine absolute molecular weights.130  This 
method gives the most accurate results if changes in dn/dc values are large enough, which 
is not always the case.  In the event that dn/dc values are too low, other detection 
methods such as refractive index can be employed and molecular weights can be 
determined by comparing the materials to standards such as polystyrene.  For this work, 
light scattering determination of absolute molecular weights was attempted for all 
materials, although in some cases dn/dc were too low and relative molecular weights 
(relative to polystyrene) were determined instead. Table 4.4 summarizes the GPC data 
for the polyphosphazenes based on non-functional amino acids.  
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Table 4.4: GPC analysis of PP-A100, PP-F100, and PP-M100 materials using triple 
detection and refractive index detection. A (-) indicates that analysis using that 
detection method was not possible and the relative molecular weights are calculated 
based on polystyrene standards. 
 
As an example of the overlap of the traces collected from GPC for the triple detection 
method, the traces from all four detectors (refractive index, right angle light scattering, 
low angle light scattering, and viscometery) for the PP-M100 material synthesized via the 
one-pot room temperature method has been included in Figure 4.11.  Only the refractive 
index traces are included for the remaining polymers, which can be seen in Figure 4.12.  
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Figure 4.11: Detector signal versus retention volume (mL) traces from GPC analysis 
of PP-M100  synthesized via the 1P RT method. Detector traces correspond to 
refractive index (red), right angle light scattering (green), low angle light scattering 
(black) and viscometer (blue).  
          
Figure 4.12: GPC traces from the refractive index detector for PP-A100 (----1P RT, - 
- - RT 2S), PP-F100 (---- 1P RT, - - - RT 2S), and PP-M100 (---- 1P RT, - - - RT 2S). 
 The traces from the four detectors (Figure 4.11) overlap well indicating that readings 
from all of the detectors corroborate with each other.  As such, the light scattering 
detection traces and measured dn/dc values can be used to determine the absolute 
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molecular weights of the polymers with the assumption that the materials are 
homopolymers and therefore, there are no unsubstituted P-Cl bonds remaining in the 
materials.130  This is a reasonable assumption for all of the materials except the PP-F100 
synthesized via the room temperature two-step method as it gave 2 signals rather than 1 
in 31P NMR, indicating the possibility of a partially substituted polymer (likely some 
phosphorus atoms with only one phenylalanine ethyl ester attached and a remaining P-Cl 
bond rather than two phenylalanine ethyl esters attached). Therefore, the absolute 
molecular weights for PP-F100 1P RT, PP-M100M 1P RT, and PP-M100 RT 2S can be 
considered valid. Another note to consider with light scattering detection for absolute 
molecular weight analysis is that PDI values are underestimated using this technique and 
should be taken with caution.130 Unfortunately, similar polyphosphazenes have not been 
analyzed using a triple detection method for GPC in published literature and therefore the 
values determined in this work cannot be compared to cited values.      
For the polymers that could not be analyzed via light scattering detection due to low 
dn/dc values, refractive index detection was used instead and molecular weights were 
calculated relative to polystyrene standards (see Table 4.4).  From the refractive index 
traces (Figure 4.12), it is evident that PP-F100 materials tend to give rise to bimodal 
chromatograph indicating that there is likely a mixture of high and low molecular weight 
polymers, which is also evident from the large PDIs.  Overall, the relative molecular 
weights of the non-functional amino acid ester based polyphosphazene materials of this 
work appeared to be lower than those of the literature.83, 84, 94, 97, 115, 117, 118 This is likely 
due to the presence of moisture during the polymerization and substitution steps of the 
synthesis in the new techniques. Moisture has been shown to initiate premature 
hydrolysis of the materials leading to decreased molecular weights.81  It is interesting to 
note that the molecular weights of the materials from the one-pot method are higher than 
those from the traditional two-step reaction, indicating that this method may even 
increase molecular weights further if applied to inert atmosphere reactions.  This was 
surprising as lower pH solutions have been shown to increase the rate of degradation of 
poly[(amino acid ester)phosphazene]s and forming the free base in solution during the 
substitution has the potential to release hydrochloric acid.81  The exception to this is with 
the PP-F100 materials but the relative molecular weights of the RT 2S are vastly different 
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than the remainder of the materials and should be considered with caution.  The two 
peaks in the 31P NMR spectra are also an indication that this material may not actually be 
the expected material proposed and therefore comparison to this material should be used 
sparingly or not at all. The substantial difference in absolute molecular weights versus 
relative molecular weights could be accounted for by differences in behavior of the 
polymers in the GPC eluent (10 mM n-butylammonium nitrate in THF).  For example, 
the conformation of the polystyrene standards may take on a compact shape in an attempt 
to exclude the eluent thus giving rise to a smaller hydrodynamic radius, whereas the 
polyphosphazenes may take on an extended conformation in which the eluent is free to 
interact with the polymer leading to a larger hydrodynamic radius for a polyphosphazene 
than polystyrene of the same molecular weight.131 These differences in conformation can 
lead to problems in calculating the molecular weights of the polyphosphazenes based on 
polystyrene standards. Despite this, poly[(amino acid ester)phosphazene]s based on 
alanine ethyl ester, phenylalanine ethyl ester, and methionine ethyl ester, have been 
successfully synthesized and characterized (FTIR, 1H NMR, 31P NMR, TGA, DSC, and 
GPC) in a non-inert atmosphere with a simplified substitution method that eliminated the 
requirement of liberating the free base of the amino acid ester hydrochloride salt prior to 
substitution.  These two new methods (polymerization and one-pot substitution) will be 
applied further for the development of novel materials with functional handles for 
biomolecule conjugation. 
4.3 Esterification of Fmoc- and Boc-Glu(OBzl)-OH 
Although amino acid esters with no functionality in their side chains, like alanine, 
phenylalanine, and methionine, are readily available as their hydrochloride salts, amino 
acid esters with added functional groups in their side chains, like glutamic acid, aspartic 
acid, and lysine, are not and must therefore be synthesized before incorporation into 
poly[(amino acid ester)phosphazene]s.  Glutamic acid was selected as the functional 
amino acid to be co-substituted with the non-functional amino acids of the base polymers 
due to its carboxylic acid group that can be used to attach small molecules and proteins 
and potentially enhance cell-material interaction.  Glutamic acid was chosen over aspartic 
acid, which also contains a carboxylic acid group, because of its extra methylene in the 
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side chain that extends the functional group out further from the polymer backbone 
decreasing the likelihood of unsuccessful biomolecule conjugation due to steric hindrance 
alone.  Lysine is another viable option as a functional amino acid co-substituent with its 
amine group in the side chain, although it was not considered in this work. 
Since glutamic acid could not be purchased as the ethyl ester at the C terminus, variations 
with the N terminus and side chain carboxylic acid orthogonally protected were acquired 
instead and the C terminus was esterified with ethanol in-house.  Fmoc and Boc protected 
N termini with a benzyl ester protected side chain were selected based on their 
availability, as Fmoc and Boc protected amino acids are common in peptide synthesis132, 
133, relatively inexpensive, and mild deprotection conditions are required (mild base and 
acid, respectively).134  The benzyl ester protecting group of the side chain was selected on 
the basis of its base stability and deprotection using hydrogenation rather than acid, 
which could cause cleavage of the amino acid esters or hydrolysis of the 
polyphosphazene backbone.134 It is important that the glutamic acid side chain be 
protected since it can also act as a nucleophile in the substitution with 
poly[(dichloro)phosphazene], which would lead to a mixture of amino acid esters bound 
through both the nitrogen of the N terminus and the oxygen of the carboxylic acid side 
chain.  This could also be problematic as the two reactive sites could react with each 
other forming amide bonds and causing crosslinking of the polymers, which is not ideal.  
Esterification of the C terminus was attempted using a carbodiimide coupling chemistry 
method that was previously reported135.  In this cited  paper,  esterifications on Boc 
protected amino acids were attempted, although it was predicted that it may also work for 
Fmoc protected amino acids since only catalytic amounts of base were required.  In fact  
successful esterification of Boc-Glu(OBzl)-OH with methanol (MeOH), t-butanol (t-
BuOH), and benzyl alcohol (PhCH2OH) nucleophiles was shown135 although ethanol 
(EtOH) had not been investigated.  In this work, ethyl esterification of both Fmoc-
Glu(OBzl)-OH and Boc-Glu(OBzl)-OH were attempted, although initial experiments 
with Fmoc-Glu(OBzl)-OH led to a mixture of products as determined by 13C and 1H 
NMR. It is believed that the base-labile Fmoc group was cleaved during the esterification 
giving way to potential self-condensation reactions and a plethora of side products, which 
could not be removed using standard liquid-liquid extraction purification.  Further 
80 
 
experiments with Fmoc-Glu(OBzl)-OH were not attempted and esterification of Boc-
Glu(OBzl)-OH was pursued.  Boc- Glu(OBzl)-OH was successful esterified with ethanol 
via the DMAP and EDC coupling chemistry 135 as determined by 1H NMR analysis of the 
starting material in comparison to the esterification product (Figure 4.13). The 
appearance of the quartet at 4.16 ppm and the triplet at 1.24 ppm corresponding to the 
methylene and methyl protons of the ethyl ester, as well as the disappearance of the broad 
singlet at 10.61 ppm from the COOH indicate complete esterification of the C terminus. 
The purification of the product was modified from that of the paper by performing the DI 
water washes with 60°C DI water rather room temperature since ureas, which are the 
byproduct of carbodiimide coupling chemistry, are known to be more water-soluble at 
higher temperatures and remain dissolved in the aqueous layer upon cooling.136  Initial 
esterifications gave 1H NMR spectra that indicated incomplete removal of urea byproduct 
impurities in the Boc-Glu(OBzl)-OEt product but upon implementation of the higher 
temperature washes, these impurities were successfully removed leaving only pure Boc-
Glu(OBzl)-OEt.  Before the esterified glutamic acid could be used in substitution 
reactions with poly[(dichloro)phosphazene], its amine terminus needed to be deprotected 
so that the amine could act as a nucleophile in the substitution reaction.  
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Figure 4.13: 1H NMR spectra of the esterification with ethanol and deprotection 
with 25% TFA in DCM of Boc-Glu(OBzl)-OH (black). The ethyl esterified product, 
Boc-Glu(OBzl)-OEt, is shown blue and the Boc deprotected product, TFA-/H3N+-
Glu(OBzl)-OEt,  is shown in green. Unlabeled peaks in the Boc-Glu(OBzl)-OEt and 
TFA-/H3N+-Glu(OBzl)-OEt spectra are equivalent to the labeled peaks with the 
same chemical shift in the Boc-Glu(OBzl)-OH spectrum. 
4.4 TFA Deprotection of Boc-Glu(OBzl)-OEt 
The Boc protecting group on amines has been shown to be removed by 50% 
trifluoroacetic acid (TFA) in dichloromethane (DCM), so this deprotection step was 
employed to the Boc-Glu(OBzl)-OEt molecule synthesized in Section 3.3.134  From 1H 
NMR analysis, it was observed that this concentration of TFA also lead to partial 
deprotection of the benzyl ester of the side chain (appearance of a broad singlet at 11.98 
and singlet at 2.19 ppm, presumably indicating COOH and toluene, respectively).  In an 
effort to deprotect the Boc group and minimize concurrent benzyl deprotection, 25% 
TFA in DCM was attempted.  This method was successful in deprotecting the Boc group 
while maintaining the integrity of the benzyl ester as is shown in Figure 4.13, which is 
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observed as a disappearance of the singlet at 1.24 ppm corresponding to the Boc 
protecting group and the appearance of a broad singlet at 8.29 ppm which represents the 
amine protons. 
4.5 Macromolecular Co-Substitution of Functional and Non-
Functional Amino Acid Esters 
In order to improve cell-material interactions, more often than not biomolecules are 
attached to the materials, either through adsorption or by covalent linkage to the scaffold 
itself.  With adsorption, the biomolecules can quickly diffuse away from the material 
once submerged in culture media or body fluid if the non-covalent interactions are weak 
leading to decreased efficiency and minimal improvement in cell-material interactions.53  
Conjugation of the biomolecules through covalent bonds, on the other hand, prevents this 
diffusion problem and maintains the biomolecule at the material surface, ideally leading 
to a sustained and enhanced effect on the cell-material interactions.  As such, the 
development of materials containing functional handles for biomolecule attachment is 
being actively pursued.53  In this work, glutamic acid, with its carboxylic acid functional 
group in the side chain, was explored as a co-substituent in poly[(amino acid 
ester)phosphazene]s, giving the mixed polymers a reactive site for biomolecule 
conjugation.   
Initial substitution reactions investigated the sequential addition of the amino acid esters, 
where the bulkier substituent (glutamic acid ethyl ester in this case) was reacted first, 
followed by the less bulky amino acid ester (alanine ethyl ester, phenylalanine ethyl ester, 
or methionine ethyl ester) in excess, as is described in the literature.  In these reactions, 
the polymer precipitated out of solution before complete substitution was achieved, 
making co-substitution via this method unfeasible.  This problem is likely due to the 
glutamic acid ester substituents being already bound either directing the subsequent 
substitution in a tactic fashion that leads to an insoluble polymer or that the glutamic acid 
substituents cause crosslinking in the polymer also leading to insolubility issues. 
Therefore, a new step-wise synthesis was employed that reacted half of the total less 
bulky and non-functional amino acid ester first, followed by all of the required amount of 
glutamic acid ester, and completion of substitution with an excess of the non-functional 
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amino acid ester.  The reasoning behind this method was to eliminate the proposed 
glutamic acid interactions described above that lead to precipitation by partially 
substituting the poly[(dichloro)phosphazene] with the non-functional amino acid esters, 
which prevent the glutamic acid ester substituents from grouping together.  This method 
was used to make polymers with approximately 90% substitution of the non-functional 
amino acid ester and 10% benzyl protected glutamic acid ethyl ester.  These functional 
polymers (PP-A90E*10, PP-F90E*10, and PP-M90E*10) were then characterized by FTIR, 1H 
NMR, 31P NMR, TGA, DSC, and GPC and compared to their non-functional base 
polymers made from the one-pot room temperature synthesis method.  It was not possible 
to compare the characterization data to literature values, as these are novel compounds 
that have not been previously published.  
4.5.1 FTIR, 1H NMR, and 31P NMR Characterization  
Table 4.5 summarizes the spectroscopic characterization using FTIR, 1H NMR, and 31P 
NMR along with percent yields for the three poly[(amino acid ester)phosphazene]s co-
substituted with a non-functional amino acid ester (alanine, phenylalanine, or methionine) 
and the functional glutamic acid ethyl ester. 
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Table 4.5: Summary of percent yields, 1H NMR, 31P NMR and FTIR 
characterization of the co-substituted poly[(amino acid ester)phosphazene]s. 
 
The FTIR spectra of the co-substituted poly[(amino acid ester)phosphazene]s in 
comparison to their parent base polymers and TFA-/H3N+-Glu(OBzl)-OEt are shown in 
Figures 4.14 – 4.16. 
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Figure 4.14: FTIR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-A90E*10 (red) , 
and PP-A100 synthesized via the 1P RT method (blue). 
 
Figure 4.15: FTIR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-F90E*10 (red) , 
and PP-F100 synthesized via the 1P RT method (blue). 
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Figure 4.16: FTIR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-M90E*10 (red) , 
and PP-M100 synthesized via the 1P RT method (blue). 
The overlapped 1H NMR spectra of TFA-/H3N+-Glu(OBzl)-OEt, the co-substituted 
poly[(amino acid ester)phosphazene]s, and their base non-functional polyphosphazenes 
for all three of the functional polymers are presented in Figures 4.17 – 4.19.   
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Figure 4.17: 1H NMR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-A90E*10, 
(red), and PP-A100 from the 1P RT method (blue).  
 
Figure 4.18: 1H NMR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-F90E*10 
(red), and PP-F100 from the 1P RT method (blue). 
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Figure 4.19: 1H NMR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-M90E*10 
(red), and PP-M100 from the 1P RT method (blue). 
From the FTIR and 1H NMR of all of the co-substituted poly[(amino acid 
ester)phosphazene]s, it is clear that the benzyl protected glutamic acid ethyl ester 
substituent has been successfully incorporated as a co-substituent in all of the materials.  
This was demonstrated by the presence of FTIR peaks from both the base 
polyphosphazene material (PP-A100, PP-F100, and PP-M100) and from the TFA-/H3N+-
Glu(OBzl)-OEt amino acid ester substituent. For example, in the PP-A90E*10 FTIR 
spectrum we see a peak at approximately 1740 cm-1 that corresponds to the C=O of the 
ester group of the amino acid backbones and another peak at approximately 1660 cm-1 
that identifies the C=O of the ester group in glutamic acid side chain.  In 1H NMR spectra 
of the co-substituted poly[(amino acid ester)phosphazene]s, the peaks with correct 
chemical shift and multiplicity that are equivalent to the parent non-functional polymer 
and glutamic acid ethyl ester substituent are all present. For example, in PP-A90E*10 the 
multiplet at 7.23 ppm corresponds to the aromatic protons of the benzyl protecting group 
in glutamic acid ethyl ester, whereas the triplet at 1.18 ppm represents the terminal CH3 
group of the ethyl ester on alanine.  From 31P NMR, it is again clear that the polymers 
were formed with the appearance of a singlet, for all except PP-F90E*10, around 0 ppm 
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and the disappearance of the singlet at approximately -17 ppm for the 
poly[(dichloro)phosphazene] linear precursor (see Table 4.5 for exact chemical shifts).  
In the case of PP-F90E*10 a two-hump peak was again observed like with the PP-F100 
synthesized via the RT 2S method. In this case, the peak could again correspond to 
phosphorus atoms that have residual chlorine atoms bound but could also indicate 
tacticity in the polymer where initial phenylalanine substitution directs the incorporation 
of the glutamic acid ester co-substituent.  Two peaks in the 31P NMR could potentially 
indicate that the phenylalanine ethyl ester substituents selectively attached on either side 
of the same phosphorus atom, giving rise to one of the peaks, leaving the glutamic acid 
ester substituents to also attach to the same phosphorus atom as themselves, giving rise to 
the second peak (i.e. phosphorus atoms with two phenylalanine groups and others with 
two glutamic acid groups).   
Considering that in 1H NMR peak areas correlate to relative numbers of protons, 
integration of the peaks solely from the non-functional amino acid ester and solely from 
the functional glutamic acid ester were compared to determine the amounts of each of the 
co-substituents on the polymer.  The reaction schemes were designed to theoretically 
incorporate 10% of benzyl protected glutamic acid ethyl ester with the remaining 90% 
being substituted by the non-functional amino acid esters although steric hindrance and 
other factors may have limited the actual amount of the glutamic acid ester that was 
actually incorporated. The experimentally determined percentages of benzyl protected 
glutamic acid ethyl ester substituents were 6.8, 7.7, and 9.3% for the PP-A90E*10, PP-
F90E*10, and PP-M90E*10, respectively. 
4.5.2 TGA, DSC, and GPC Characterization 
This next section describes the thermal properties and molecular weights of the functional 
polyphosphazenes.  As with the non-functional base polymers, thermal data was collected 
to determine the decomposition, glass transition, and melting temperatures, where 
applicable, for all of the functional polymers co-substituted with benzyl protected 
glutamic acid ethyl ester and results are summarized in Table 4.6.  
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Table 4.6: Summary of thermal data from TGA and DSC analysis for PP-A90E*10, 
PP-F90E*10, and PP-M90E*10 polymers. The decomposition temperatures are 
presented as the peak decomposition temperatures rather than onset, meaning they 
are the values of maximal rate of change in weight % for all phases of the 
decomposition (i.e. maxima of the derivative of weight % plot). 
 
Thermogravimetric (TGA) analysis data showing thermal decomposition properties are 
shown in Figure 4.20. 
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Figure 4.20: TGA analysis for the PP-A90E*10, PP-F90E*10, and PP-M90E*10 polymers. 
The first graph represents the weight percent vs. temperature, where as the second 
graph shows the derivative of weight percent vs. temperature. 
From TGA analyses, all three of the polymers exhibited similar thermal stability with 
onset of decomposition in excess of approximately 150°C for all.  Unlike the single phase 
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decomposition observed with the PP-A100 base polymer, all of the functional 
polyphosphazenes showed two-step decomposition processes, similar to PP-F100 and PP-
M100.  The reason behind the two-step decompositions with the functional polymers is the 
presence of the C=C bonds aromatic bonds of the benzyl protecting group, and 
phenylalanine side chain in PP-F90E*10, which give rise to the second peak of the process 
as these bonds are more stable than the C-C and C-H bonds of the amino acid backbone.  
All of the TGA traces were relatively similar to one another, which is to be expected 
when the all contain not only C-C and C-H bonds but also the more stable C=C bonds. 
Like with the non-functional base polymers, the decomposition profiles do not 
completely reach a weight % of zero since the inorganic backbone of the 
polyphosphazenes does not decompose in the temperature range of the experiments. 
The differential scanning calorimetry (DSC) analyses of the functional polyphosphazenes 
are presented in Figure 4.21.  
 
Figure 4.21: DSC thermograms of PP-A90E*10, PP-F90E*10, and PP-M90E*10 
polymers. The glass transition temperatures (Tgs), which were collected from the 
second heating cycle, range from -49.4 to +44.5°C. 
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Overall the Tgs of the functional polymers follow the same trend as those of the non-
functional base polymers, where the Tgs are in the order PP-A100 ≈ PP-M100 < PP-F100. 
Due to the small percent substitution of the glutamic acid substituent, approximately 
10%, the functional polymers are expected to have Tgs on par with their non-functional 
counterparts. The Tgs are also in approximately the same range as for the base polymers 
except with the methionine based functional polymer, which is much lower than the base 
polymers.  This is likely due to the role that molecular weight plays in the glass transition 
temperature of polymers.  
Like with the non-functional polymers, GPC analysis was performed using triple 
detection and refractive index detection alone to determine the absolute and relative 
molecular weights, respectively.  In this case, since the polymers are no longer 
homopolymers their dn/dc must be approximated using their parent non-functional 
polymers, leading to uncertainty in the absolute molecular weights calculated from light 
scattering-based triple detection methods. Therefore, it is more appropriate to consider 
the relative molecular weights that have been calculated based on polystyrene standards 
rather than the absolute molecular weights, although the absolute molecular weights have 
been included in this work for completeness. The results of GPC analysis of the 
functional polyphosphazenes are summarized in Table 4.7.  
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Table 4.7: GPC analysis of PP-A90E*10, PP-F90E*10, and PP-M90E*10 materials using 
triple detection and refractive index detection. A (-) indicates that analysis using 
that detection method was not possible and the relative molecular weights are 
calculated based on polystyrene standards. 
 
 
       
Figure 4.22: GPC traces from the refractive index detector for PP-A90E*10 (black), 
PP-F90E*10 (blue), and PP-M90E*10 (red). 
From the refractive index traces (Figure 4.22) it is evident that PP-F90E*10 material 
produced a  bimodal spectra indicating that there is likely a mixture of higher and lower 
molecular weight polymers.  Overall, the relative molecular weights of the co-substituted 
amino acid ester based polyphosphazene materials are lower than those of the non-
functional parent polymers. This could be the case if the higher molecular weight 
polymers have a tendency to precipitate out of solution prior to complete substitution, 
leading to their filtration and loss during the purification steps. This is postulated due to 
the fact that initial experiments where benzyl protected glutamic acid ethyl ester was 
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added before the non-functional amino acid ester led to problems with precipitation of the 
polymers before complete substitution was achieved, indicating that if large amounts 
glutamic acid substituents were present on the polymer that solubility issues could arise.  
Despite the lower molecular weights of the polymers, overall characterization by FTIR, 
1H NMR, 31P NMR, TGA, DSC and GPC have proven that co-substituted 
polyphosphazenes of alanine ethyl ester, phenylalanine ethyl ester, methionine ethyl 
ester, and benzyl protected glutamic acid ethyl ester polymers are feasible for the 
development of poly[(amino acid ester)phosphazene]s with functional handles for 
biomolecule conjugation. 
4.6 Hydrogenation of Glutamic Acid Co-Substituted 
Polyphosphazenes for Model Compound Conjugation 
After the benzyl protected glutamic acid substituent is successfully incorporated into 
polyphosphazenes, it is necessary to remove the benzyl ester protecting group to free the 
carboxylic acid functionality, as it is this group that allows covalent attachment of 
biomolecules.  Benzyl esters are commonly removed by either highly acidic conditions, 
which would be detrimental to the polymer backbone and lead to ester hydrolysis in this 
case, or by hydrogenation using a palladium catalyst. In this work, a Pd/C catalyst system 
was attempted for the hydrogenation of the benzyl protecting groups. The effect of 
hydrogenation reactions on P=N bonds is not well-documented in the literature, although 
their dissimilarity from C=C bonds lead us to believe that they may withstand 
hydrogenation conditions. The PP-A90E*10 material was dissolved in anhydrous ethanol 
and mixed with a suspension of Pd/C catalyst under an H2 atmosphere for 3.5 hours. The 
reaction successfully removed the benzyl esters as indicated by the disappearance of the 
multiplet at 7.23 ppm in 1H NMR corresponding to the aromatic protons of the benzyl 
group (see red spectrum of Figure 4.12).  Unfortunately, the reaction also reduced the 
P=N bonds of the polymer backbone and led to backbone cleavage.  This was identified 
by the disappearance of the peak at around 1.84 ppm in 31P NMR, which is indicative of 
the presence of the polymer backbone.  Another indication that the hydrogenation 
reaction attacked the polymer backbone was that the materials were water-soluble after 
hydrogenation, which is not the case for the intact materials.  To overcome this problem 
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it is suggested that allyl protected glutamic acid groups should be used in place of benzyl 
protected ones. For allyl protecting groups, which are both acid and base stable, a 
Pd(PPh3)4 transition metal catalyst be used for deprotection in place of  hydrogenation to 
prevent disruption of the P=N bonds. Morozowich et al.90 have shown successful 
removal of allyl protecting groups on antioxidant substituted polyphosphazenes without 
any detriment to the backbone using this catalyst system.     
4.7 Cytotoxicity and Cell Proliferation on Non-Functional and 
Functional Two-Dimensional Polyphosphazene Films 
Upon successful synthesis of the base and functional polymers using the new one-pot 
room temperature synthesis method, it was necessary to evaluate the interaction of the 
materials with cells to ensure their cytocompatibility.  For this, two-dimensional films of 
the polymers were coated onto the bottom of the wells of a 96-well tissue culture plate, 
then cytoxicity and cell proliferation were analyzed using MTT assays. A mouse 
fibroblast cell line (NIH-3T3) was used to evaluate the effect of the polymers on cell 
viability and metabolic activity over a time period of five days. Figure 4.23 shows the 
metabolic activity of the cells normalized to TCPS at day 1.  As can be observed from the 
overall comparison of the two graphs in Figure 4.23, preconditioning the materials 
overnight in HBSS leads to an increase in initial cell viability (higher absorbances at day 
1 with preconditioning), although it does not change the fact that with and without 
preconditioning cells are capable of proliferating on the materials over the entire 5-day 
span (metabolic activity persists until day 5 on the materials with and without 
preconditioning).  It is also clear from the confocal microscopy images of Figure 4.25 
that the cells on the unconditioned materials (Panels A, C, E, G, I, K, and M) are still 
viable based on their elongated morphology with long filamentous F-actin protrusions 
(green). Preconditioning is common practice in cell studies with biomaterials as it acts as 
a buffering period in which the materials are washed of small molecules on their surface 
that can disrupt proper interaction of the cells with the materials themselves.50, 51, 53, 94, 114  
Moreover, the preconditioning period “wets” the surface of the materials allowing them 
to interact properly with the aqueous cell suspensions, rather than seeding the cells on the 
dry films, which may suppress cell-material interaction and lead to diminished cell 
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attachment, and thus reduced viability, on the materials. Therefore, all statistical analysis 
of comparisons between materials in terms of cell viability and proliferation were 
conducted for the preconditioned films. At Day 1, both of the phenylalanine-based 
polyphosphazenes (PP-F100 and PP-F90E*10) showed significantly higher (p<0.001) 
metabolic activity of fibroblasts in comparison to the TCPS positive control.  At Day 3, 
the PP-F90E*10 material continues to exhibit significantly higher (p<0.01) metabolic 
activity of the cells in comparison with the TCPS control.  By Day 5, it seems that cell 
proliferation begins to plateau, which may be due to crowding of the fibroblasts, and the 
PP-F90E*10 material performs on par with the TCPS control in terms of metabolic activity.  
For the PP-F100 material, the metabolic activity of the fibroblasts in comparison to TCPS 
was not significant by Day 3. Taken together, these indicate that the phenylalanine-based 
polyphosphazenes synthesized via the new 1P RT method are suitable as biomaterials and 
should be explored further.  For the remainder of the materials, it should be noted that 
despite having initial metabolic activity lower than the TCPS controls, these materials are 
also non-cytotoxic.  This is shown in Figure 4.24, where it is clear that the metabolic 
activity is increasing from Day 1 to Day 5 for all of the functional and non-functional 
polymers, despite lower initial activity at Day 1, indicating that the cells are thriving on 
these materials.  The decreased Day 1 activity levels may be due to decreased affinity of 
the cells to attach to the materials initially, although once they have successfully attached 
they are capable of surviving. The confocal images of the preconditioned materials in 
Figure 4.25 (Panels, B, D, F, H, J, L, and N) also shows that the cells are 
morphologically healthy and spreading well on the materials.    
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Figure 4.23: Fibroblast metabolic activity as determined by MTT assay grouped by 
day to compare metabolic activity levels between materials and TCPS. Cells were 
seeded at 8,000 cells/well on 2-D polyphosphazene films (PP-A100, PP-F100, PP-M100, 
PP-A90E*10, PP-F90E*10, and PP-M90E*10) that were either unconditioned or 
preconditioned in HBSS at room temperature overnight. The cells were cultured for 
1, 3, and 5 days with 5 replicates for each.  The data are presented as the mean ± 
standard deviation and are normalized to TCPS at Day 1. (** = p<0.01, *** = 
p<0.001) 
 
Figure 4.24: Fibroblast metabolic activity as determined by MTT assay grouped by 
material to show non-cytotoxicity from day 1 to day 5. Cells were seeded at 8,000 
cells/well on 2-D polyphosphazene films (PP-A100, PP-F100, PP-M100, PP-A90E*10, PP-
F90E*10, and PP-M90E*10) that were preconditioned in HBSS at room temperature 
overnight. The cells were cultured for 1, 3, and 5 days with 5 replicates for each.  
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The data are presented as the mean ± standard deviation and are normalized to 
TCPS at Day 1. 
 
 
Figure 4.25: Confocal microscopy images showing the morphology and spreading of 
fibroblasts on the unconditioned and preconditioned polyphosphazene materials 
after 3 days of culture.  The cells were seeded at a density of 30,000 cells/well on the 
polymer coated glass coverslips in a 24-well tissue culture plate. Untreated glass 
cover slips were used as a positive control in these experiments. The fibroblasts were 
stained for F-actin (green) and nuclei (blue). Scale bar = 20 μm (panel B).  
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4.8 Electrospinning of Poly[(amino acid ester)phosphazene]s and 
PCL Blend Materials 
In order for the new materials to be useful in scaffolds for tissue engineering, they must 
be processable into 3-D constructs using one of the scaffold fabrication techniques 
alluded to in the introduction.  As such, preliminary proof of concept, electrospinning 
was attempted using PP-A100 materials synthesized via the 1P RT reaction.  Since similar 
polyphosphazene materials had been successfully electrospun into fibrous mats in the 
literature, the electrospinning parameters from these experiments were used as a starting 
point.  Some difficulties in attempting to implement these conditions with the new PP-
A100 materials were that the molecular weights of the polymers were vastly different, 
therefore requiring changes to the concentrations to maintain sufficient viscosity of the 
polymer solution, and also that the solvents used in the literature were relatively toxic 
(ex. hexafluoroisopropanol and trifluoroethanol) in comparison to standard solvents (ex. 
chloroform, ethanol, and tetrahydrofuran) and thus, suitable replacements were 
required.64, 105, 137, 138 It was also suspected that the charged nature of the polymers 
synthesized in this work, in comparison to the uncharged polymers of the literature, may 
pose a problem with electrospinning since the technique is based on the exploitation of 
electrical charges.  
Initial trials investigated PP-A100 concentrations between 3 and 37 weight by volume 
percent (w/v %) in solvents and co-solvent systems based on CHCl3, DCM, EtOH, THF, 
and DMF.  Sufficient viscosities were achieved to form the polymer jet in 
electrospinning, although it was noticed that upon hitting the collector the fibers 
remained standing up out from the aluminum foil, rather than laying flat on the surface.  
This was presumably due to a build up of charges from the positively charged nitrogen 
atoms of the polyphosphazene backbone repelling one another and pushing the newly 
deposited fibers of the collector towards the needle tip. It is believed that a rotating 
mandrel setup, rather than a stationary collector, may help with this problem by forcing 
the extended polymer chains to collapse back on one another as the mandrel rotates, 
allowing a fibrous mat to be collected.  
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Unfortunately, a rotating mandrel setup was unavailable to test this theory and instead 
polymer blends of PP-A100 and polycaprolactone (PCL), a well-known biocompatible and 
degradable polymer, were attempted to be electrospun as proof that fabricating fibrous 
mats of these polymers was feasible. Various w/v % concentrations and ratios of PP-A100 
to PCL were attempted, although a mixture of 50% PP-A100 and 50% PCL gave the best 
results and was capable of forming non-woven fibers as determined by scanning electron 
microscopy (SEM) imaging.  The spinning solution was a 5 w/v % solution of 50% PP-
A100 and 50% PCL by weight in DCM. The electrospinning parameters were an 18kV 
accelerating voltage, 18-gauge needle tip, 9 cm working distance between the tip of the 
needle and the collector, and flow rate of 0.1 mL/h. Although the electrospinning 
parameters were not optimized to give ideal fiber diameters and morphologies, it can be 
seen from the SEM images (Figure 4.26) that the polymer blend gave relatively uniform 
fiber diameters with a bead-free morphology and good porosity, which are key aspects to 
a successful scaffold.  Optimization of the electrospinning parameters could enable the 
fabrication of fibrous mats based on polyphosphazene/PCL blend materials with 
appropriate fiber diameters, morphology, and porosity for vascular tissue engineering 
applications.          
 
 
Figure 4.26: Scanning electron micrographs of electrospun fibers of a 5 w/v % 
polymer solution in DCM containing 50% PP-A100/50% PCL by weight. 
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4.9  Novelty of This Work 
Overall, the research conducted in this thesis has led to the successful synthesis of 
polyphosphazene materials based on both non-functional and functional amino acid esters 
using a simplified method. The facile synthesis is an improvement over the demanding 
techniques previously presented in the literature, overcoming the necessity of specialized 
equipment to maintain an inert atmosphere and the use of toxic solvents. The materials 
were characterized extensively and exhibited partial cationic charge at the nitrogen atom 
of the amino acid, which had not been reported in the literature before with similar 
materials. Lastly, novel polyphosphazenes containing mixed substituents of non-
functional amino acids and functional glutamic acid were synthesized which are materials 
that had not been reported prior to this work. 
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5 Conclusions and Future Directions 
5.1 Conclusions 
In this work, the objectives outlined in Chapter 1 were all successfully realized, except 
for the biomolecule conjugation due to problems with deprotection.  A thermal ring 
opening polymerization method that did not require controlled moisture-free atmospheres 
was developed and optimized for best conversion of the hexachlorocyclotriphosphazene 
trimer to linear poly[(dichloro)phosphazene] (PDCP). From there, the PDCP was 
successfully used in the synthesis of a family of non-functional poly[(amino acid 
ester)phosphazene]s, based on L-alanine ethyl ester, L-phenylalanine ethyl ester, and L-
methionine ethyl ester, using three different substitution methods. Upon characterization 
by FTIR, 1H NMR, and 31P NMR spectroscopic studies, it was determined that all three 
methods produced materials which were similar to those described in the literature, 
indicating that the new facile one-pot room temperature (1P RT) method, which also 
eliminated the necessity of an inert atmosphere, was suitable for future polyphosphazenes 
syntheses.  The new 1P RT method was selected over the low temperature two-step 
method (LT 2S), based on yields and characterization data, for further comparison to the 
materials synthesized via the room temperature two-step (RT 2S) method in terms of 
thermal and molecular weight analysis. It was also observed that the 1P RT gave 
improved purity and higher molecular weights over the well-established room 
temperature two-step (RT 2S) method that is routinely used in the literature. Despite the 
fact that the molecular weights of the polyphosphazenes synthesized using these two 
methods were lower in comparison with the literature, they were a step towards 
polyphosphazene synthesis that did not require advanced synthetic chemistry and 
expensive laboratory equipment. These two new methods (polymerization and one-pot 
substitution) were then employed to fabricate novel functional co-substituted poly[(amino 
acid ester)phosphazene]s with functional handles for biomolecule immobilization.  Prior 
to the co-substitution, Boc protected glutamic acid ethyl ester was successfully 
synthesized via the esterification of Boc-Glu(OBzl)-OH with ethanol, a feat that had yet 
to be accomplished. The newly synthesized Boc-Glu(OBzl)-OEt was then deprotected 
and used in a substitution reaction with poly[(dichloro)phosphazene] to give a family of 
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novel functional co-substituted polyphosphazenes based on L-glutamic acid, L-alanine, 
L-phenylalanine, and L-methionine.  A step-wise substitution method was developed for 
the formation of these novel polymers, where the non-functional amino acid ester was 
partially substituted, followed by complete addition of stoichiometric amounts of the 
functional glutamic acid substitution, and finally fully substituted by addition of excess 
non-functional amino acid ester. These new materials were fully characterized using 
FTIR, NMR, TGA, DSC, and GPC.  Unfortunately, the polymer backbone was affected 
when hydrogenation of the benzyl protecting group was attempted and further work in 
this area is required before biomolecule conjugation can be successfully achieved 
although similar materials with allyl protecting groups are expected to overcome this. As 
it is important that these materials be biocompatible for use in vascular tissue engineering 
applications, their cytotoxicity and cell proliferation characteristics were evaluated using 
MTT assays and confocal imaging of immunofluorescently tagged cells. MTT assays of 
the non-functional and functional polymers showed non-cytotoxicity of the 
preconditioned two-dimensional films towards NIH-3T3 mouse fibroblasts over a study 
period of five days. The MTT assays also showed enhanced cell attachment at Day 1 
versus TCPS positive controls for the PP-F100 and PP-F90E*10 phenylalanine-based 
polyphosphazenes and significant metabolic activity of cells seeded on these materials, 
which is promising for their use in biomedical applications. Lastly, electrospinning was 
used to develop fibers from the new polyphosphazene materials. While preliminary trials 
with PP-A100 alone were unsuccessful in fabricating fibers, a 50% PP-A100 and 50% PCL 
blend was effectively used to develop fibers at a polymer concentration of 5 w/v % in 
DCM. These fibers were then imaged using scanning electron microscopy (SEM) to 
show the bead-free morphology and nanometer-scale diameter of the fibers. It is 
important that biomaterials can be processed into desired configurations for use in 
biomedical applications and in this study not only 2-D films but also 3-D fibers were 
successfully fabricated based on the poly[(amino acid ester)phosphazene]s and blends 
thereof. Overall, this work suggested that poly[(amino acid ester)phosphazene]s can be 
synthesized in non-inert atmosphere and that non-functional and functional co-substituted 
polyphosphazenes based on L-phenylalanine ethyl ester may be suitable for biomedical 
applications such as tissue engineering. 
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5.2 Future Directions 
In light of the work presented here, future work on this project should include: 
 Substituting the benzyl group with a different protecting group like allyl and 
deprotection with Pd(PPh3)4 catalyst, followed by conjugation of a biomolecule 
known to enhance cell-material interactions 
 Performing electrospinning trials with a rotating mandrel for 100% 
polyphosphazenes polymer solutions or optimization of the electrospinning 
process for polyphosphazenes/PCL blend materials 
 Performing in vitro degradation studies on two-dimensional polymer and three-
dimensional non-woven fibrous mats from electrospinning 
 Performing long-term  in vitro cell studies using not only fibroblasts but also 
other native blood vessel cells, like endothelial cells and vascular smooth muscle 
cells, on 2-D films and 3-D mats of the non-functional and functional poly[(amino 
acid ester)phosphazene]s 
 Perform mechanical testing (cyclic loading tensile testing) on 2-D films and 3-D 
fibers of the poly(amino acid ester)phosphazene materials to ensure 
appropriateness for vascular tissue engineering applications 
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Appendices 
Appendix 1: Summary of literature values for the characterization and thermal 
properties of poly[(amino acid ester)phosphazene]s. GPC data are relative to 
polystyrene standards in all cases. 
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Appendix 2: Enlarged regions of the PP-A100 FTIR spectra showing P=N and P-NH 
peak broadening. The spectra correspond to L-alanine ethyl ester hydrochloride 
(black), and PP-A100’s made by the LT 2S (blue), 1P RT (green), RT 2S (red) 
reactions.  
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Appendix 3: Enlarged regions of the PP-F100 FTIR spectra showing P=N and P-NH 
peak broadening. The spectra correspond to L-phenylalanine ethyl ester 
hydrochloride (black), and PP-F100’s made by the LT 2S (blue), 1P RT (green), RT 
2S (red) reactions.  
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Appendix 4: Enlarged regions of the PP-M100 FTIR spectra showing P=N and P-NH 
peak broadening. The spectra correspond to L-methionine ethyl ester hydrochloride 
(black), and PP-M100’s made by the LT 2S (blue), 1P RT (green), RT 2S (red) 
reactions.  
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